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2. ABBREVIATIONS
ABD Actin binding domain
BCA Bicinchoninic acid
BH4 Tetrahydrobiopterin
Biotin-HPDP N-[6-(biotinamido)hexyl]-3’-(2’-pyridylditio)propionamide
BPAG1 Bullous pemphigoid antigen 1
BSA Bovine serum albumin
CaM Calmodulin
cAMP Cyclic 3’, 5’-adenosine monophosphate
CAMK Calmodulin-dependent kinase
Cdk Cyclin-dependent kinase
CH Calponin homology
Cys Cysteine
DAG Diacylglycerol
DTT 1,4-Dithiothreitol
EB Epidermolysis bullosa
EBS Epidermolysis bullosa simplex
EBS-MD Epidermolysis bullosa with muscular dystrophy
eNOS Endothelial nitric oxide synthase
FAC Focal adhesion contact
FCS Fetal calf serum
FMN Flavin mononucleotide
GFAP Glial fibrillary acidic protein
GFP Green fluorescence protein
HD Hemidesmosome
HRPO Horse radish peroxidase
IF Intermediate filament
IFAP Intermediate filament associated protein
IPTG Isopropyl thio-β-D-galatoside
MACF Microtubule–actin crosslinking factor
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MAP Microtubule-associated protein
MMTS Methyl methanethio-sulfonate,
MT Microtubule
MTJ Myotendinous junctions
MTOC Microtubule-organizing center
NF Neurofilament
NLS Nuclear localization signal
NMJ Neuromuscular junctions
NO Nitric oxide
NOS Nitric oxide synthase
OA Ocadaic acid
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate buffered saline
PI Processive index
PKA Protein kinase A (cAMP-dependent kinase)
PKC Protein kinase C
PMA Phorbol-12-myristate-13-acetate;
PPase Protein phophatase;
PS Phosphatidylserine
R Repeat
ROS Reactive oxygen species
SDS Sodium dodecylsulfate
SNAP S-nitroso-N-acetylpenicillamine
ULF Unit-length filament
wt Wild type
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3. SUMMARY
The cytolinker protein plectin plays a crucial role in maintaining the integrity of the
cytoskeleton by interlinking intermediate filaments (IFs) with other cytoskeletal network
systems, and anchoring them to the plasma membrane. It also serves as a scaffolding
platform for signaling cascades, and may well have also a function in IF network assembly
and dynamics. The plectin molecule, with its high molecular weight (>500,000), has a three-
domain organization, where a central α-helical rod domain is flanked by two terminal
globular domains. Harboring a unique phosphorylation site for protein kinase Cdk1 and
binding sites for different IF proteins and for a variety of proteins involved in signaling,
plectin’s C-terminal domain consisting of six structural repeats (R1-6) is of strategic
functional importance. Depending on the species, there are at least 13 cysteines in plectin’s
C-terminal domain, 4 of which reside in the repeat domain 5 (R5). Cysteines may play an
important role in stabilizing the protein structure and conformation.
The first part of the thesis was focused on the purification and crystallization of the
plectin fragments harboring the IF-binding site. All recombinant proteins were purified by
at least one purification step and homogeneity of the proteins used for crystallization was
confirmed by size exclusion chromatography. Extensive crystallization screening revealed
that only a cysteine-free version of plectin R5 and a fragment corresponding to repeat
domains R4-5 were able to form crystals. However, only small rod-shaped or clustered
needle-shaped crystals occurred. Neither optimizing crystallization conditions nor
macroseeding led to crystals with dimensions appropriate for collecting X-ray diffraction
data.
In the second part, I investigated the structural and biological functions of R5
cysteines and the effects of plectin nitrosylation on vimentin-binding and involvement in IF
collapse using biochemical and functional analyses. Performing cysteine to serine
mutagenesis and biochemical analyses I showed that the four cysteines of R5 can form intra-
and intermolecular disulfide bridges. In addition it could be shown that the single cysteine
in vimentin as well as the cysteines in R5 formed disulfide bonds between each other.
However, vimentin-binding was significantly more efficient when R5 was in its reduced
form, probably reflecting distinct conformations of the reduced and the nonreduced forms.
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Out of the four cysteines in R5 only one (Cys4) was found to be particularly reactive with
respect to disulfide bridges formation ability and serving as a target for nitrosylation in vitro.
Using immortalized endothelial cells, I could show that endogenous plectin is the target of
S-nitrosylation in vivo and I found that NO donor-induced IF collapse proceeded
dramatically faster in plectin-deficient compared to wild-type cells. Additionally, I observed
that actin stress fibers accumulated in the center of the cells upon NO donor treatment. By
measuring the amount of NO released from endothelial cells upon eNOS stimulation, I found
that NO production was dramatically reduced in plectin-deficient compared to wild-type
cells. NO release correlated with the expression level of eNOS and its activation status. Also
the distribution of eNOS corresponded with its activation in both cell types, as it was
localized at the cell periphery in plectin-deficient cells (inactive form) and diffusely
distributed in wild-type cells (active form).
In a third part of my thesis I studied the effects of plectin phosphorylation on
vimentin-binding and on IF network formation and dynamics. Using an in vitro binding
assay I found that vimentin and plectin phosphorylation by Cdk1 (a typical mitotic event)
influenced the interaction of both proteins. In particular, phosphorylated vimentin in the
presence of phosphorylated plectin R5-6 led to the formation of globule-like structures of
various sizes. Very similar structures, mainly in the form of granules and squiggles were
observed in newly spreading postmitotic fibroblasts and in cells after trypsinization/replating.
I could show that the formation of these vimentin intermediates were plectin dependent, as
they showed association with plectin and were not observed in the absence of plectin. In
addition in mitotic cells I observed multipolar spindles in plectin-deficient contrary to wild-
type cells. Moreover, while the majority of wild-type cells undergoing cytokinesis showed
an uneven distribution of the vimentin network to their daughter cells, a much more even
distribution was observed in plectin knockout cells. Also I found that mitosis progressed
faster in plectin knockout compared to wild-type fibroblasts. The data presented in my thesis
suggest that plectin is not only a major organizing element of the IF network cyto-
architecture, but also has an important function in IF network assembly and dynamics.
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4. ZUSAMMENFASSUNG
Das Cytolinkerprotein Plectin spielt bei der Aufrechterhaltung der Integrität des Zytoskeletts
eine entscheidende Rolle, indem es Intermediärfilamente (IFs) mit anderen zytoskelettären
Netzwerksystemen verbindet und diese an der Plasmamembran verankert. Weiters dient es
als strukturelles Grundgerüst für Signalkaskaden und dürfte ebenfalls eine Funktion in der
Netzwerkanordnung und – dynamik haben. Das Plectinmolekül mit seinem hohen
Molekulargewicht (>500,000), besitzt eine Drei-Domänen-Organisation, wobei eine zentrale
α-helikale Stabdomäne von zwei terminalen globulären Domänen begrenzt wird. Indem es
eine einzige Phosphorylierungsstelle für die Proteinkinase Cdk1 and Bindungsstellen für
verschiedene IF-Proteine und eine Vielfalt an Proteinen, die im „Signaling“ involviert sind,
besitzt, ist die C-terminale Domäne von Plectin (bestehend aus den sechs strukturellen
Wiederholungen - R1-6) von strategisch wichtiger Bedeutung. Abhängig von der Spezies, gibt
es zumindest 13 Cysteine in der C-terminalen Domäne von Plectin, vier davon befinden sich
in der Repeatdomäne R5. Cysteine könnten einen wichtigen Beitrag zur Stabilisierung der
Konformation von Proteinen leisten.
Der erste Teil der Arbeit ist auf die Aufreinigung und Kristallisation von
Pectinfragmenten, in denen die IF-Bindungsstelle lokalisiert ist, fokussiert. Alle
rekombinanten Proteine wurden durch mindestens einen säulenchromatographischen Schritt
gereinigt und die Homogenität der Proben durch Größenausschluss-Chromatographie
bestätigt. Umfangreiches Kristallisationsscreening zeigte, dass nur die cysteinfreie Version
des Plectin R5 und ein Fragment, das die Repeat-Domäne R4-5 enthielt, in der Lage waren,
Kristalle zu bilden. Aber auch in diesen Fällen traten nur kleine stabförmige oder sternförmig
angeordnete nadelige Kristalle auf. Weder die Optimierung der Kristallisationsbedingungen
noch Großansätze (Macroseeding) führten zu Kristallen mit Dimensionen, die für die
Röntgenbeugungsanalysen geeignet waren.
Im zweiten Teil der Arbeit untersuchte ich strukturelle und biologische Funktionen der
in R5 enthaltenen Cysteine und die Auswirkungen ihrer Nitrosylierung auf Plectins
Vimentinbindung und den Kollaps von IFs. Mit Hilfe von Cystein-Mutagenese (zu Serinen)
zeigte ich, dass vier der in der R5 Repeat-Domäne enthaltenen Cysteine intra- und
intermolekulare Disulfidbrücken bilden konnten. Darüber hinaus, konnte gezeigt werden, dass
das einzige in Vimentin enthaltene Cystein mit den R5-Cysteinen Disulfidbindungen eingehen
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können. Dennoch war die Vimentinbindung signifikant effektiver wenn das R5-Fragment in
reduzierter Form vorlag. Von den vier Cysteinen in R5 wurde nur eines (Cys4) gefunden, das
besonders reaktiv hinsichtlich Disulfidbrückenbildung war und auch in vitro nitrosiliert
werden konnte. Unter Verwendung immortalisierter Endothelzellen konnte ich zeigen, dass
Plectin auch in vivo S-nitrosiliert wird, und außerdem zeigte sich, dass Stickoxid (NO)-Donor-
induzierter IF-Netzwerkzerfall in Plectin-defizienten Zellen dramatisch schneller ablief als in
Wildtyp-Zellen. Zusätzlich beobachtete ich, dass sich Aktin-Stressfasern durch NO-Donor-
Behandlung im Zentrum der Zellen ansammelten. Die Messung des von Endothelzellen nach
endothelialer Stickoxidsynthase (eNOS)-Stimulation freigesetzte NO ergab, dass die NO-
Produktion in Plectin-defizienten im Vergleich zu Wildtyp-Zellen drastisch reduziert war. Die
NO-Freisetzung korrelierte mit der Menge und dem Aktivierungsstatus von eNOS. Auch die
Verteilung der eNOS entsprach ihrem Aktivierungzustand, wobei sie in Plectin-defizienten
Zellen an der Zellperipherie lokalisiert (inaktive Form) war, während in Wildtyp-Zellen eine
diffuse Verteilung (aktive Form) zu finden war.
Im dritten Teil meiner Arbeit untersuchte ich die Auswirkungen der Phosphorylierung
von Plectin auf dessen Vimentinbindung, IF-Netzwerkbildung und Filamentdynamik. In
Bindungsstudien fand ich heraus, dass die Phosphorylierung von Vimentin und Plectin durch
die Mitose-spezifische Kinase Cdk1 deren Interaktion beeinflusste. Im speziellen führte
phosphoryliertesVimentin, in Gegenwart der phosphorylierten Bindungsdomäne Plectin R4-
5, zur Bildung globulärer Strukturen unterschiedlicher Größe. Sehr ähnliche Strukturen,
vorwiegend in Form von Granula und kurzen Filamenten, wurden in postmitotischen
Fibroblasten und in Zellen unmittelbar nach der Trypsinierung beobachtet. Ich konnte zeigen,
dass die Bildung dieser Vimentin-Filament-Zwischenstufen von Plectin abhängig war, da sie
nur in Plectin-positiven Zellen zu beobachten war. Zusätzlich beobachtete ich in mitotischen
Zellen multipolare Spindeln in Plectin-defizienten, jedoch nicht in Wildtyp-Zellen. Während
der Großteil der Wildtyp-Zellen nach der Cytokinese eine ungleiche Verteilung des Vimentin-
Netzwerks auf die Tochterzellen zeigte, wurde eine wesentlich gleichmäßigere Verteilung in
Plectin-knockout Zellen beobachtet. Darüber hinaus zeigte sich, dass die Mitose in Plectin-
knockout Fibroblasten schneller als in Wildtyp-Zellen ablief. Die in meiner Arbeit
präsentierten Ergebnisse deuten darauf hin, dass Plectin nicht nur ein bedeutendes
Organisationselement der IF-Netzwerk-Cytoarchitektur darstellt, sondern auch eine wichtige
Rolle bei dynamischen Prozessen des IF-Netzwerks spielt.
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5. INTRODUCTION
5.1. The cytoskeleton
Shapes and sizes of mammalian cells are fascinating and nearly as varied as the animals
themselves. Cytoarchitecture is responsible for this diversity and also contributes to most
functions of each cell type. The cytoskeleton is a fibrous meshwork of three major
components – actin microfilaments, microtubules and intermediate filaments (IFs).
Components of the cytoskeleton are assembled from soluble precursors, under the precise
control of many different cellular processes and other proteins which crosslink the filaments.
The cytoskeleton is found in all eukaryotic cells, provides the cell with mechanical strength,
it is responsible for its shape and integrity and it is essential for the organization of cell
movement in many aspects. It supports the fragile plasma membrane and provides
mechanical linkages. It enables the cells to change their shape and to move from one place
to another. Actin microfilaments play essential role in cell polarity and migratory or
contractile processes. In contrast, IFs provide intracellular mechanical strength and are
consequently abundant in tissues, such as epidermis and muscles that undergo physical stress.
On the other hand, microtubules are essential for intracellular vesicle, organelle and protein
delivery, whereas the mitotic spindle formed from microtubules plays a role in the
chromosome alignment dynamics and segregation during mitosis. Many cellular functions,
such as sperm cell swimming, neuronal axon and dendrite extension or the crawling of white
blood cells are dependent on the cytoskeleton.
Interesting findings in the cytoskeleton research came from the family of cytoskeletal
cross-linking proteins, known as cytolinkers or plakins, which were identified on the basis
of IFs and membrane junctional complexes (Green et al., 1992; Ruhrberg and Watt, 1997;
Wiche, 1998). These proteins are encoded by complex genes, which encode several isoforms,
with potential unique functions and with varying abilities to associate with different
cytoskeletal systems.
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5.2. Actin microfilaments and microtubules
As essential components of the cytoskeleton, actin microfilaments and microtubules are
polymers with structural polarity assembled from highly conserved globular proteins that
have nucleotide-binding and hydrolyzing activity.
Microfilaments with a diameter of 5-9 nm are assembled from single subunits, called
actin. In its monomer form, actin is usually referred to as G-actin. Each protein unit is about
42 kDa in size and contains an adenine nucleotide. When these monomers polymerize they
associate head-to-tail to yield the F-actin. This process is usually accompanied by hydrolysis
of bound ATP to ADP. Actin filaments are crosslinked and packed in the living cells together
by different accessory proteins, making this abundant complex much stronger than single
filaments. Actin exists in three different isoforms, α, β, and γ that partially differ in their
amino acid sequence. While isoforms α and β were found together in nearly all non-muscle
cells, γ actin is expressed only in muscle cells (Pollard and Cooper, 1986).
Microtubules are formed from heterodimeric protein subunits, α- and β-tubulin, each
about 450 amino acids and 50 kDa in size, which are tightly bound together by non-covalent
bonds. As in actin, each monomer contains a bound nucleotide, but tubulins use the GTP and
GDP instead of ATP and ADP. Also as in actin, the dimers polymerize end to end, result in
a polar filament. However, microtubules are composed of 13 parallel filaments
(protofilaments) encircling the hollow core and they are much more rigid than the actin
microfilaments. In contrast to actin microfilaments whose assembly is initiated at the cells
periphery, microtubules are nucleated deep within the cytoplasm, from the structures near the
nucleus called microtubule–organizing center (MTOC) (Kirschner and Mitchison, 1986).
5.3. Intermediate filaments
In contrast to microtubules and microfilaments, IF networks are formed from filamentous
proteins, that have no enzymatic activity and form polymers without structural polarity. In
most vertebrates, IFs form extensive networks throughout the cytoplasm, that extends from
the nuclear surface to the cell periphery. As rope-like structures, able to resist deformation,
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IFs are considered to be the most rigid component of the cytoskeleton and to be responsible
for the maintenance of the cell shape. Thus, IFs are particularly prominent in cells that are
exposed to mechanical stress.
5.3.1. Classification
Primary structure, gene structure, assembly properties or their developmentally regulated
tissue specific expression patterns divide IF proteins into five distinct types (Strelkov et al.,
2003). In contrast to keratins – IF protein types I and II that form obligatory heteropolymers
– type-III IF proteins (vimentin, desmin, glial fibrillary acidic protein, and peripherin) form
homopolymeric IFs. Vimentin has been found expressed in mesenchymal and some
ectodermal cells during the early developmental stages, often forming a network before the
expression of differentiation–specific IF proteins, such as desmin or neurofilament proteins.
The three neurofilament protein subunits (NF-L, NF-M and NF-H), nestin, syncoilin and α-
internexin comprise type–IV IF proteins. Finally, the nuclear IF protein lamin A and its splice
variant lamin C, together with lamins B1 and B2, form the type–V group.
5.3.2. Domain structure and function
All cytoplasmic IFs have a common secondary structure. The central rod domain of about
310 amino acids is flanked by globular non-α-helical head and tail domains of variable size
(Geisler and Weber, 1982). The α-helical central rod domain with a heptad repeat of
hydrophobic amino acids is subdivided into the coil segments 1A, 1B, 2A, and 2B that are
connected by short linkers (Parry and Steinert, 1999). The rod domain is the most conserved
region among the different isoforms, but the N- and C-terminal globular domains can differ
much.
Little is known about the functions of head and tail domains. While, N-terminal head
domains are essential for IFs assembly, C-terminal tail domains might be involved in the
lateral interactions and organization of the IF networks (Herrmann et al., 2003). Within these
globular non-α-helical domains are present several phosphorylation sites that are involved in
the regulation of their assembly/disassembly and subcellular organization (Kumar et al.,
2002; Helfand et al., 2003).
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5.3.3. IFs assembly
IFs are assembled in a three-step process, where gradual association of the dimers (Steinert,
1993) leads to the formation of tetramers (Herrmann and Aebi, 1999), which then rapidly
associate laterally to form unit-length filaments (ULFs) (Strelkov et al., 2003). In particular,
the vimentin ULFs appear to contain about sixteen ~46 nm long dimers (Herrmann et al.,
1996). Subsequently, ULFs anneal longitudinally into loosely packed filaments. Finally, these
filaments undergo an internal rearrangement of subunits resulting in the radial compaction
of the filament (Strelkov et al., 2003). In general, the conditions for the in vitro poly-
merization and depolymerization of IFs are similar. In vitro polymerization of the vimentin
into 10 nm filaments is determined by pH and ionic strength, increased ionic strength leads
to the formation of the filaments from soluble subunits (Zackroff and Goldman, 1979;
Strelkov et al., 2003).
In vivo studies of living cells by using rhodamine- and green fluorescent protein
(GFP)-tagged vimentin, or immunofluorescence microscopy of fixed cells, have shown that
type-III IF proteins exist in several intermediate states: non-filamentous granules, short
filamentous structures that are known as squiggles, and longer filaments (Vikstrom et al.,
1992; Prahlad et al., 1998; Yoon et al., 1998). The form of vimentin within the granules is
unknown, although granules probably contain IF intermediates such as dimers, tetramers or
ULFs. However, purified vimentin microinjected into living cells immediately forms non-
filamentous granules before assembling into longer IFs (Vikstrom et al., 1989). On the basis
of observations during the spreading process, it is evident, that IF granules and squiggles
have an important role in the assembly of the IF network found in interphase cells. During
the early stages of spreading of fibroblasts, a fraction of GFP-vimentin was found in non-
membrane bound and non-filamentous forms, termed vimentin granules, which were most
visible at the edge of the cells. These particles seemed to be replaced by the filamentous
squiggles as the spreading progresses. Ultimately, the number of vimentin granules and
squiggles decreases together with the appearance of extensive IF networks. This phenomenon
is not vimentin-specific, as IF particles have also been observed in cultured nerve cells (Yabe
et al., 1999b), spreading epithelial cells (Windoffer and Leube, 1999a) and in several types
of mitotic cells (Rosevear et al., 1990).
In fact, the changes observed in IF network reorganization during different stages of
mitosis resemble those seen in spreading cells. Both vimentin and keratin networks seem to
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be converted into granules distributed through the cytoplasm during the transition from
prophase to metaphase (Rosevear et al., 1990; Windoffer and Leube, 1999a). During
cytokinesis, the majority of these granules are present at the centrosomal region of the
daughter cells, where they form a perinuclear filamentous cap (Rosevear et al., 1990). From
these observations, it is obvious that at least part of the IF network could be assembled
sequentially in several distinct steps: non-filamentous granules, short fibrous squiggles and
long fibrils (Prahlad et al., 1998; Chou and Goldman, 2000). The movement of these
intermediates and the formation of IF networks in spreading cells have been shown to depend
on microtubule integrity and require microtubule-based motors such as kinesin and dynein
(Prahlad et al., 1998; Helfand et al., 2002).
5.4. Cytolinker proteins
Microfilaments, microtubules and IFs are the main components of the cytoskeleton
responsible for maintaining the cell shape and resistance to the external oxidative or
mechanical forces. In fact, these three cytoskeletal elements should be stabilized and
interlinked together. The plakin protein family comprises large multifunctional proteins
referred to as cytoskeletal linker proteins or cytolinkers that mediate such interactions
(Wiche, 1998). Cytolinkers interlink different cytoskeletal networks and connect them to
membrane-associated adhesive junctional complexes, such as desmosomes and hemi-
desmosomes. Seven members of the plakin family have been identified, including
desmoplakin, plectin, bullous pemphigoid antigen 1 (BPAG1), ACF7, also called
microtubule-actin crosslinking factor (MACF), envoplakin, periplakins and epiplakin (Fig.
1) (Leung et al., 2002). Plakin family members are defined by the presence of a plakin
domain and/or one or more plectin repeat domains (plectin repeats) (Janda et al., 2001).
There are also other domains that are common to some but not all members, such as a
calponin-type actin-binding domain (ABD), a heptad repeat-containing coiled-coil rod
domain, a spectrin-repeat-containing rod domain and a microtubule (MT)-binding domain.
The plakin domain, which consists of 4–8 spectrin repeats interrupted by an SH3
domain, has been predicted to comprise six α-helical segments that are organized as
antiparallel α-helical bundles (Virata et al., 1992; Roper et al., 2002). All family members
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except epiplakin contain the plakin domain, which is important in targeting plakins to
specific cell junctions. Plakin or plectin repeat domains, which contain a module and linker
region, comprise varying numbers of the repeat (R) domains, ranging from none in periplakin
to 13 in epiplakin. Each repeat is composed of four complete and one partial highly
conserved 38-residue motifs. These repeat domains can be categorized into A, B and C types.
The linkers connecting the modules are less conserved and of variable lengths. The linker
region between the repeat B- and C-type modules harbors the IF-binding site. The ABD
which is homologous to the ABDs of the spectrin family members refer to spectraplakin
family, consists of two calponin homology (CH) domains (Leung et al., 2002).
Desmoplakin, a component of desmosomes, besides plectin is the best plakin
characterized. It is located in the innermost portion of the desmosomal plaque where it is
thought to play a role in attaching IFs to the cell surface (Franke et al., 1987; Green et al.,
1990). By anchoring IFs to the plasma membrane and forming a subcellular scaffold, it also
contributes to the assembly and/or stabilization of desmosomes (Gallicano et al., 1998).
There are two closely related splice forms of desmoplakin, DPI (322 kDa) and DPII (259
kDa) (Green et al., 1990; Virata et al., 1992). Both forms were found in all types of epithelia,
but DPI was also found in heart muscle cells (Franke et al., 1987). Desmoplakin is a
dumbbell-shaped molecule where the central rod domain is flanked by N-terminal and C-
terminal globular domains (O’Keefe et al., 1989). The N-terminal part consists of the plakin
domain, while the C-terminus is built from three repeat domains of the types A, B, and C
(Green et al., 1990). The linker region between the repeats B and C is responsible for the
direct binding to the various types of IFs (Stappenbeck et al., 1993; Kouklis et al., 1994). A
mutation in the human desmoplakin gene causes autosomal dominant skin disorder called
striated palmoplantar keratoderma, which is characterized by the hyperkeratosis of the palms
and feet (Armstrong et al., 1999).
Bullous pemphigoid antigen 1 (BPAG1) is a plakin protein that is associated with
the hemidesmosomal plaque. The BPAG1 gene encodes several structurally distinct proteins,
which are differentially distributed over various tissues. BPAG1-a is produced in the pituitary
primordial and in the dorsal root ganglia (Leung et al., 2001). BPAG1-b in the developing
mouse embryos is restricted to the heart, skeletal muscle, and bone cartilage of the vertebrae.
BPAG1-e is expressed in basal epithelial cells and was found associated with hemi-
desmosomes. The expression of BPAG1-n, also called dystonin, has been proposed to occur
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in neuronal cells at a low level (Brown et al., 1995; Yang et al., 1996). The coiled-coil rod
domain of the BPAG1-e is flanked by a N-terminal plakin domain and repeat domains of the
type B and C at the C-terminal part. BPAG1-n is similar to BPAG1-e, except for an ABD at
its N-terminus (Fig. 1). BPAG1-a has an ABD and a plakin domain, like BPAG1-n, but its
rod domain is composed of 23 spectrin repeats, and the C-terminal domain is harboring a
microtubule-binding site. These interaction domains are also present in BPAG1-b which
contain additionally one repeat of the A type between its spectrin repeats and the plakin
domain. BPAG1 deficiency in mice leads to degeneration of the sensory nervous system
(Duchen, 1976; Dowling et al., 1997).
Microtubule-actin cross-linking factor (MACF), also known as ACF7, as a paralogue
of BPAG1-a, contains an ABD, a plakin domain, a rod domain with 23 spectrin repeats, and
an MT-binding domain. It coordinates and interlinks microtubules and actin filaments and is
expressed ubiquitously in mouse embryos, with the highest level in the nervous system and
intermediate to high levels in skeletal muscle and myocardium (Leung et al., 1999). Studies
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Figure 1. Schematic diagram of the plakin family cytolinker proteins. Various subdomains; actin binding domain
(ABD), coiled-coil rod domain, spectrin repeats-containing rod domain and plectin repeat domains are specified in
the legend. The homologous repeat domains of the A, B and C type consist of a 38 amino acid residues-long motif,
tandemly repeated five times.
of its Drosophila homologue – kakapo – revealed that gene mutations result in defects in cell
differentiation and development of the nervous system (Gregory and Brown, 1998).
Epiplakin was found as an epidermal autoantigene from a patient with a subepidermal
blistering disease that resembled bullous pemphigoid (Fujiwara et al., 1996). In contrast to
other plakin family members the whole molecule of epiplakin consists of sixteen repeats of
the B type (Spazierer et al., 2003). It is expressed abundantly in skin, small intestine and
salivary gland and at lower levels in lung, liver and uterus (Spazierer et al., 2003). Mutations
causing disease have not been reported to date.
Periplakin and envoplakin are components of the cornified envelope in the outer layer of
the stratified epithelium (Steinert et al., 1999). They were found in keratinizing and non-
keratinizing stratified epithelia and in two-layered and transitional epithelia, such as the
mammary gland and bladder (Simon and Green, 1984; Ruhrberg et al., 1996). They connect
cytoskeletal structures with cell adhesion complexes. The rod domain of envoplakin is N-
terminally flanked by a plakin domain, and C-terminally by C type repeat and a linker region
(Fig. 1). While all proteins of the plakin family form two stranded coiled-coil homodimer
(O’Keefe et al., 1989; Tang et al., 1996), the evidence suggests that envoplakin and
periplakin might interact with each other via their rod domains forming heterodimers
(Ruhrberg et al., 1997; DiColandrea et al., 2000). Up to date, there are no confirmed events
of inherited diseases known which would arise from mutations in these proteins. Recent
studies suggest, however, that envoplakin is not required for cornified envelope assembly
(Määttä et al., 2001).
5.4.1. The cytolinker protein plectin
Plectin, as the most versatile cytoskeletal linker protein known, has a high molecular weight
(>500,000) and is composed of a central ~200 nm long α-helical coiled coil rod domain
flanked by globular domains. Plectin, which is expressed in a variety of mammalian tissues
and cell types, was originally identified as a major component of IF-enriched extracts from
rat glioma C6 cells (Pytela and Wiche, 1980). It interlinks IFs with microtubules and
microfilaments and anchors them to the subplasma membrane skeleton and to plasma
membrane-cytoskeleton junctional complexes (Wiche, 1998). The fact that plectin was found
concentrated at hemidesmosomes (Rezniczek et al., 1998), desmosomes (Eger et al., 1997),
Z-disk structures and dense plaques of striated and smooth muscle, intercalated discs of
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cardiac muscle and focal adhesion contacts (FACs) (Seifert et al., 1992; Andrä et al., 1997)
implicates a role of the protein in linking the cytoskeleton to plasma membrane junctions.
It is particularly prominent in stratified simple epithelia, various types of muscle, and cells
forming the blood brain barrier (Wiche, 1989; Errante et al., 1994). In several tissues, plectin
expression was found to be prominent in the cells forming the tissue layers at the interface
between tissues and fluid-filled cavities, including the surfaces of kidney glomeruli, liver
bile canaculi, bladder urothelium, gut villi, epidermal layers lining the cavities of brain, and
endothelial cells of blood vessels (Wiche et al., 1983; Errante et al., 1994; Yaoita et al.,
1996).
Molecular structure
The molecular mass of plectin was estimated as 300 kDa based on the co-migration of the
protein with subcomponents of high molecular mass microtubule-associated proteins (MAPs)
in SDS-PAGE (Pytela and Wiche, 1980). The precise size prediction of plectin isoforms
varies from 507 to 527 kDa depending on several alternative first coding exons (Elliott et
al., 1997). Rotary shadowing electron microscopy of purified plectin revealed a dumbbell-
like structure, and its microscopic dimensions and gel permeation HPLC data indicated a
molecular weight of over 1.1x106, suggesting that plectin molecules in solution exist as
dimers (Foisner and Wiche, 1987; Weitzer and Wiche, 1987). The interaction with IF
involves a specific binding domain located in the C-terminal domain of the protein (Nikolic
et al., 1996), whereas a functional actin-binding domain (ABD) is situated within the N-
terminal domain (Elliott et al., 1997; Andrä et al., 1998) and binding sites for integrin β4 are
located at both ends (Rezniczek et al., 1998) (Fig. 2).
The building block of plectin’s C terminus is a repeat domain, known as the plakin
or plectin repeat domain, from now referred to as repeat domain (Janda et al., 2001; Leung
et al., 2002). Repeat domains consist of a conserved core domain, or module, built from 4.5
tandemly repeated copies of a 38-amino acid motif (the “PLEC repeat”, according to
databases SMART, http://smart.embl-heidelberg.de/ and Pfam, http://www.sanger.ac.uk/cgi-
bin/pfam/) (Sonnhammer et al., 1997; Schultz et al., 1998). The modules are separated from
each other by linker sequences of variable lengths. The concept of the module as the basic
structure of the C-terminal domain of plakin proteins has been validated by the crystal
structure determination of the two desmoplakin repeat domains (Choi et al., 2002). The C-
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terminal part of plectin (~1900 amino acids) represents six highly homologous repeat
domains (R1-R6) of about 300 amino acids each, with five of the B type and one of the C
type. The linker region between modules 5 and 6 contains the IF-binding site, whereas the
tail of module 6 harbors a putative MT-binding site. Secondary structure analysis revealed
that plectin repeats are similar to the ankyrin repeat motif (Janda et al., 2001), having a
hairpin-helix-loop-helix (ß2α2) structure (Sedgwick and Smerdon, 1999; Kobe and Kajava,
2000). Accommodation of the six repeat plectin domains within the globular C-terminal
plectin domain, which has an estimated diameter of 9 nm (Foisner and Wiche, 1987),
requires tight packing. Janda et al. (2001) proposed a circular arrangement of antiparallel-
oriented plectin repeat 1-5 domains with the repeat 6 domain in their center. Such a structure
could be stabilized by hydrophobic interactions between residues on the surface of each
repeat domain and/or through cysteines via disulfide bond formation upon oxidative stress.
Molecular interactions
Plectin has been characterized as an essential component of cytoarchitecture. Due to its
multiple functions in many cellular processes, plectin can be defined as a universal cytolinker
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Figure 2. Schematic diagram of plectin’s subdomain structure and plectin repeat domains 1-6. (A) N-terminal
domain with its ADB, central rod and C-terminal domain consisting of six repeats connected by linker regions of
different lengths. (B) Schematic hypothetical diagram of plectin repeats arranged as a compact 6-cylinder structure
stabilized by disulfide bridges and a schematic structure of one repeat, showing the module’s cylindrical shape
predicted on the basis of known 3D structure of desmoplakin (modified from Janda et al., 2001).
protein. Several studies have shown that plectin interacts with all of the fundamental
cytoskeletal filament systems, the plasma membrane, desmosomes and hemidesmosomes.
Plectin has been identified as a direct interaction partner of vimentin (Pytela and Wiche,
1980; Wiche et al., 1982) and of other cytoplasmic IF subunit proteins, including GFAP,
epidermal cytokeratins, neurofilament triplet proteins, and desmin (Foisner et al., 1988) as
well as the nuclear IF protein, lamin B (Foisner and Wiche, 1991). The IF-binding site of
plectin linking the C-terminal repeat 5 and 6 domains has been mapped to a stretch of ~50
amino acid residues (Nikolic et al., 1996). A basic amino acid residue cluster within a typical
bipartite nuclear localization sequence (NLS) motif was identified as a crucial element of this
site. In vitro experiments showed that the plectin repeat 5 domain bound to type III IF
proteins (vimentin) with preference over type I and II cytokeratins 5 and 14 (Steinböck et
al., 2000).
The evidence from both in vitro and in vivo experiments indicates that plectin’s
interaction with IFs is differentially regulated by phosphorylation involving different types
of protein kinases (Foisner et al., 1991; Foisner et al., 1996). Plectin’s interaction with lamin
B was found to be significantly decreased upon phosphorylation of either binding partner by
cAMP-dependent protein kinase (PKA) or Ca2+/phosphadidyl-dependent protein kinase C
(PKC), while its binding to vimentin was increased upon PKA phosphorylation but decreased
upon PKC phosphorylation (Foisner et al., 1991).
In the light of plectin’s role as a cytoskeletal linker element, a specific regulation of
its binding properties could have particular importance during mitosis, when the IF network
is dramatically reorganized (Malecz et al., 1996). Plectin, as a target of cyclin-dependent
kinase 1 (Cdk1), during mitosis becomes phosphorylated at a unique site (threonine 4542),
which resides in plectin’s C-terminal repeat 6 domain, not far from the IF-binding site
(Malecz et al., 1996).
Functions beyond cytolinking
Examination of cultivated plectin-deficient fibroblasts revealed a new aspect of plectin
functions. After short-term adhesion these cells showed a dramatic increase in the number
of actin stress fibers and focal adhesion contacts, compared to wild-type cells (Andrä et al.,
1998). Plectin seemed to destabilize actin filaments instead of favoring the formation of
stable adhesion complexes, as one could expect based on its stabilizing effect on hemi-
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desmosomal junctions (Andrä et al., 1998). Thus, plectin seems to act not only as a
mechanical linker of different structural elements but also as a regulator of their dynamic
rearrangements. According to this hypothesis, plectin was proposed to act as a cytoskeletal
scaffolding platform for proteins involved in signaling and cytoskeletal reorganization. Its
enormous surface area and multidomain structure would ideally be suited to facilitate such
a task (Janda et al., 2001). This notion is also supported by the high number of different
plectin-binding proteins that have been identified (Steinböck and Wiche, 1999). Among
several interaction partners linked to signaling the nonreceptor tyrosine kinase Fer binds to
plectin’s N-terminal globular domain and the absence of plectin leads to an elevation of its
kinase activity (Lunter and Wiche, 2002). The finding of a high affinity interaction between
an N-terminal plectin peptide (residues 95-117) and the ubiquitin E3 ligase Siah, suggested
a potentially new regulatory role of plectin in the selective degradation of proteins (House
et al., 2003). Using yeast two hybrid screening, RACK1, the receptor for activated C kinase,
and the regulatory γ1 subunit of AMP-activated protein kinase (AMPK), the key regulatory
enzyme of energy homeostasis, have been identified as a binding partners of plectin
(Osmanagic-Myers and Wiche, 2004; Gregor et al., 2006). Finally, plectin was found to play
a role in the regulation of keratin filament dynamics. It has been shown that upon incubation
of keratinocytes with the protein phosphatase inhibitor okadaic acid (OA), collapse of keratin
networks proceeds significantly faster in plectin-deficient compared with wild-type cells
(Osmanagic-Myers et al., 2006).
Plectin deficiency
Defects in plectin expression lead to epidermolysis bullosa simplex (EBD)-MD, a severe
hereditary skin blistering disease combined with muscular dystrophy (Gache et al., 1996;
Chavanas et al., 1996; McLean et al., 1996; Pulkkinen et al., 1996; Smith et al., 1996). The
skin pathology is due to defects in hemidesmosomes, which show disrupted anchorage of
keratins. In addition, a number of studies reported that some EBS-MD patients additionally
suffer from inspiratory stridor and respiratory distress involving laryngeal obstruction and
urethral strictures (Mellerio et al., 1997; Dang et al., 1998). A form of an inherited autosomal
dominant skin disease known as EBS-Ogna, linked to chromosome 8q24, has also been
linked to defects in the plectin gene (Koss-Harnes et al., 1997; Koss-Harnes et al., 2002).
Schröder et al. (2002) reported an EBS-MD patient with a novel homozygous 16-bp insertion
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mutation in plectin’s C-terminal domain residing in close proximity to the IF-binding site.
The latter mutation results in marked subsarcolemmal and intermyofibrillar desmin filaments
accumulation in muscle tissues that can be attributed to faulty protein-protein interaction
between the mutated plectin molecules and desmin IFs.
Plectin-null mice, generated by targeted gene inactivation (Andrä et al., 1997) showed
that while structures of desmosomes and hemidesmosomes seem to be unaffected, the
number of hemidesmosomes was significantly reduced and their mechanical stability
impaired. Skeletal muscle biopsies of plectin-deficient mice revealed an increased number
of necrotic muscle fibers, focal disruptions of sarcomeres and aberrant Z-disk formations.
Conditional gene targeting in mice revealed that in striated muscle plectin deficiency
results in progressive degenerative modifications, including detachment of the contractile
apparatus from the sarcolemma, decreased number and dysfunction of mitochondria, and
partial loss and aggregation of IF networks in distinct cytoplasmic compartments, depending
on the missing isoform (Konieczny et al., 2008). Plectin 1d and 1f, two major plectin
isoforms expressed in muscle, integrate fibers by specifically targeting and linking desmin
IFs to Z-disks and costameres, whereas plectin 1b establishes a linkage to mitochondria.
Aditionally, mouse fibroblasts and myoblasts that selectively lack this isoform but express
all others showed extensive elongation of mitochondrial networks, while other mitochondrial
properties remained largely unaffected (Winter et al., 2008). Mice with conditionally deleted
plectin in stratified epithelia died early after birth with signs of starvation, growth retardation,
and blistering on their extremities. The epidermis of this knockout was very fragile and
showed focal epidermal barrier defects caused by the presence of small skin lesions (Ackerl
et al., 2007).
5.5. S-Nitrosylation and oxidation
All proteins residing in the cytoplasm are directly exposed to oxidative stress, which leads
to formation of disulfide bridges between at least two cysteines that can contribute to
maintaining the structure of such proteins. Disulfides maintain the conformational integrity
of proteins. In their reduced state, proteins without disulfide bonds tend to be unfolded,
because they lack the stabilizing influence of these bonds. This depends however on the
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intrinsic stability of the folded conformation and upon the stabilizing contribution of any
disulfide bonds (Creighton, 1986). The formation of disulfide bonds is necessary for many
proteins, especially for their cellular function and conformational stability.
The C-terminal part of plectin contains from 13 (mouse) to 17 (human) cysteines
(Liu et al., 1996; Fuchs et al., 1999). Four of these generally highly conserved residues are
clustered in the repeat 5 domain harboring also the IF-binding site. This tempting localization
might have a functional purpose, as these cysteines could form intra- and inter-repeat
disulfide bridges, thereby providing more structural rigidity to the protein itself. Intracellular
disulfide bridge formation is likely to be of particular importance in situations where cells
have to respond to mechanical, oxidative or other types of stress. Reversible in vivo modi-
fications of cysteines by local redox changes could lead either to cysteine oxidation through
reactive oxygen species or to S-nitrosylation through reactive NO. In addition, reactive
oxygen species could convert NO into higher oxides of nitrogen and radicals, such as
peroxynitrite, which efficiently oxidize thiol groups (Lane et al., 2001).
5.5.1. Oxidative stress and vascular NO release
NO is a reactive molecule that can rapidly diffuse throughout the whole cell, which can react
with sulfur groups on cysteine residues that are present in an acid– cysteine– base motif. This
results in reversible S-nitrosylation and in the presence of reducing enzymes, such as GSNO-
reductase, may also lead to the formation of disulfide bridges between cysteine residues
(Kim et al., 2002; Liu et al., 2004). The rapid access of NO to different parts of the
endothelial cell and reactivity with a broad scale of biological molecules makes NO very
appropriate for the coordination of cellular processes through posttranslational protein
modification. Redox reactive molecules may play a role in integrating signaling events and
determine the duration and strength of signaling (Nathan, 2003). One important function of
NO in oxidative phosphorylation may be its competition with oxygen as an electron acceptor
in respiratory complex IV (Moncada and Erusalimsky, 2002). As a consequence, with
decreasing oxygen availability, NO will predominate as an electron acceptor and reduce
oxidative phosphorylation thus limiting energy expenditure.
Like for NO, reactive oxygen species may also provide permissive signaling. The
H2O2 is the predominant reactive oxygen component in the intracellular environment where
superoxide dismutase is present (Finkel, 1998). H2O2 can also react with cysteine residues
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leading to the formation of sulfenic acid (SOH) and disulfide modifications (Stuehr et al.,
2004). Similarly to NO, H2O2 can also rapidly diffuse throughout the cell. However, the
cellular events are different from that induced by NO, H2O2 results in the phosphorylation
of transcription factors such as NF-κB, AP1, and CREB1 e.g. (Finkel, 1998).
5.5.2. Regulation of eNOS activation
Endothelium-derived NO is generated from L-arginine by the endothelial isoform of NO
synthases under remarkably complex regulation (Fleming and Busse, 2003). eNOS consists
of a C-terminal reductase domain containing binding sites for the reduced form of NADPH
and the flavin cofactors FAD and flavin mononucleotide (FMN), and of an N-terminal
oxygenase domain with binding sites for heme, tetrahydrobiopterin (BH4) and L-arginine
(Fig. 3). Both terminal domains are connected by a recognition site for calmodulin (CaM).
Activation of eNOS occurs upon an increase of intracellular Ca2+ and binding of the
subsequently formed Ca2+/CaM complex which then permits the electron flux required for
NO generation (Alderton et al., 2001). Alternatively, eNOS can be activated by the
phosphorylation of the amino acid residue serine 1177 (human eNOS sequence), which then
enhances electron flux through the reductase domain and improves Ca2+ sensitivity of the
enzyme (Fleming and Busse, 2003). Several protein kinases including Akt/protein kinase B,
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Figure 3. Regulation of endothelial NO synthase (eNOS). eNOS consists of a C-terminal reductase domain con-
taining binding sites for the nicotinamide adenine dinucleotide phosphate (NADPH), flavin adenine dinucleotide
(FAD), and flavin mononucleotide (FMN), and of an N-terminal oxygenase domain with binding sites for heme (Fe),
tetrahydrobiopterin (BH4), and L-arginine (Arg). Both domains are linked by a recognition site for calmodulin
(CAM). Several amino acid residues of eNOS undergo posttranslational phosphorylation controlling the enzyme
activation. Threonine 495 is a negative regulatory site (phosphorylation is associated with a decrease in enzyme ac-
tivity). Serine 1177 combines several signaling pathways upon cell stimulation and promotes the activation of
eNOS. AMPK, 5′-AMP-activated kinase; CAM, calmodulin; CAMKII, calmodulin-dependent kinase II; IBMX,
isobutylmethylxanthine; PKA, protein kinase A; PKC, protein kinase C; S-1-P, sphingosine-1- phosphate; VEGF,
vascular endothelial growth factor (modified from Heller et al., 2006)
protein kinase A (PKA), AMPK, and calmodulin-dependent kinase II (CAMKII) have been
shown to phosphorylate serine 1177 and to participate in the eNOS activation. On the other
hand, most probably PKC basally phosphorylates the threonine 495 residue (human eNOS
sequence), which may be dephosphorylated upon stimulation of cells and its response to
bradykinin (Fleming and Busse, 2003).
In endothelial cells eNOS colocalizes with caveolae and lipid rafts of the plasma
membrane (Shaul et al., 1996; Sowa et al., 2001) and have been also found on the cyto-
plasmic face of the Golgi complex (O’Brien et al., 1995; Fulton et al., 2002; Fulton et al.,
2004). Proper subcellular localization seems to be critical for the phosphorylation and
activation of the enzyme, as mislocalization of eNOS leads to the attenuation of both,
agonist-stimulated NO release and eNOS phosphorylation (Sakoda et al., 1995; Sessa et al.,
1995; Fulton et al., 2004; Jagnandan et al., 2005).
As well as the other NOS isoforms, eNOS is an NADPH-consuming enzyme, which
ensures electron flow from the reductase domain of the enzyme toward the heme-containing
oxygenase domain. The cofactor CaM is an important checkpoint required for the shuttling
of electrons toward the heme group (Stuehr et al., 2004). In the presence of oxygen a very
reactive superoxy ferrous–peroxy ferric complex is formed. Another important checkpoint,
the eNOS cofactor BH4, facilitates the reaction of L-arginine with the electrons and oxygen,
which leads then to the formation of L-citrulline and NO (Werner et al., 2003). However, if
either BH4 or the substrate L-arginine are lacking, the superoxy ferrous–peroxy ferric
complex may dissociate and result in the formation of superoxide (if BH4 is lacking) or
H2O2 (if L-arginine is lacking) (Werner et al., 2003; Berka et al., 2004). This state of eNOS
known as “uncoupled state”, has been regarded as an abnormality of eNOS function and
was found to be associated with risk factors for atherosclerosis. Uncoupled state of eNOS
indicates that the endothelial cell can switch from a quiescent state (NO) into a state adapted
for the host defense (H2O2). In this respect, formation of the reactive oxygen species by
uncoupled eNOS could be considered as a physiological signalization during injury and
infection, and in fact it may be an essential mechanism in the host defense response.
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6. MAJOR GOALS
As described above, plectin’s C-terminal domain consists of 6 repeat domains connected by
linker regions, and the linker between repeat domains 5 and 6 is harboring the binding site
for IFs. Plectin contains at least 13 cysteines, 4 of which reside in repeat 5, and a unique
Cdk1 phosphorylation site resides in repeat 6.
Initially, the goal of my thesis was to resolve the 3D crystal structure of the repeat
domains containing plectin’s IF-binding site. In particular, the focus was on repeat domain
5 in its singular form, and in forms combined with either repeat domain 4 or 6. As
crystallization requires proteins of high purity and may not always be successful, another
goal to be approached in parallel was to study biochemical and cell biological aspects of
plectin’s interaction with vimentin. In this context it was of particular interest to study the
question, whether the binding of vimentin to plectin was affected upon oxidation of cysteines
located near the IF-binding site of plectin. To gain insight into the location and accessibility
of the cysteine residues within the repeat 5 domain, one of my goals was to generate a 3D
model of the plectin repeat 5 domain by homology modelling based on the recently solved
crystal structure of the desmoplakin repeat domain B. As the localization of cysteines in the
repeat 5 domain might serve a functional purpose I was interested if these cysteines could
form intra- and/or inter-repeat disulfide bridges and if the binding affinity of the repeat 5
domain to vimentin was affected by their oxidative state. S-Nitrosylation has a potential role
in the regulation of protein function in response to oxidative stress and therefore my next
goal was to test whether some of the cysteines are targets for nitrosylation and whether S-
nitrosylation has any effects on the structure or functions of IFs. If S-nitrosylation was found
to have consequences on plectin-regulated cellular functions the question would be whether
eNOS and/or NO production were affected.
In a third part of my thesis several questions concerning the Cdk1 phosphorylation
site near the IF-binding site were to be addressed. The first questions were whether the
binding of vimentin to plectin was affected upon phosphorylation by mitotic Cdk1 and
whether phosphorylation had an influence on IF cytoarchitecture. As a major organizing
element of IF network cytoarchitecture plectin may well affect also IF network assembly
dynamics. Therefore another question to be addressed was whether plectin deficiency has an
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influence on IF network formation in spreading cells after replating and during reformation
of IF networks after cell division. If such an influence could be found one of my goals was
to study the dynamics of this network formation in live cells using time-lapse microscopy.
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7. MATERIALS AND METHODS
7.1. Homology modeling
A model was generated by an automated homology modeling server (ExPASy proteomics
server using SWISS-MODEL-ProModII) running at the Swiss Institute of Bioinformatics
(Geneva), and GENO3D (Lyon). The structural template used for modeling was the crystal
structure of human desmoplakin repeat domain B (PDB Identifier 1LM7) (Choi et al., 2002),
which shares 73% sequence identity with plectin’s repeat 5 domain. Modeling by satisfaction
of spatial restraints was performed by the method of Combet et al. (2002). The alignment of
the target (plectin repeat 5 domain) and the template (desmoplakin B domain) was obtained
using Needleman-Wunsch global alignment algorithm on EMBL-EBI server
(http:/www.ebi.ac.uk/emboss/align/). Restraints on various distances, angles, and dihedral
angles in the sequence were derived from the alignment of the target with the template
structure. Finally, the three-dimensional (3D) model was refined by applying distance
geometry, simulated annealing and energy minimization procedures. Visualization of the 3D
structure was performed using the molecular-graphics package Yasara
(http://www.yasara.com).
7.2. cDNA constructs, plasmids, and site directed mutagenesis
Plectin’s repeat 4 and 5 domains comprise residues 3780-4024 and 4025-4367 (SwissProt
accession number P30427), respectively. The domains were amplified by PCR, using as
template a mouse plectin cDNA (exons 31 and 32; Fuchs et al., 1999), and subcloned into
pBN120, a pET15b derivative (Nikolic et al., 1996). Mutagenesis was carried out by an
overlap extension approach, or by using the QuickChange site-directed mutagenesis kit
(Stratagene) with primers designed to substitute cysteines with serines. All constructs were
verified by automated DNA sequencing. Wild-type repeat 5 domain and its cysteine mutants
were cloned by K. Abdoulrahman (PhD thesis, 2004).
For bacterial expression, full-length mouse vimentin cDNA (GenBank accession
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number M26251), including the stop codon at position bp 1879-1881, was excised from
mammalian expression vector pMCV21 and subcloned in several steps into a modified
version of plasmid pET23a (Novagen), yielding plasmid pFS129 (Steinböck et al., 2000).
Tagless vimentin encoded by pFS129 was used in all in vitro experiments.
For transfection of cells in culture (chapter 7.42), plasmid pMG3, encoding GFP-
tagged vimentin, was generated (by M. Gregor) by subcloning mouse vimentin cDNA (a
generous gift of P. Traub; plasmid pMC-V21) (Steinböck et al., 2000) into vector pEGFP-
C1 (BD Biosciences Clontech).
7.3. Proteins
7.3.1. Expression of recombinant proteins in E. coli
Recombinant proteins were expressed in the E. coli strain BL21 (DE3) after induction with
1 mM IPTG, when culture reached an OD600 of 0.5 to 0.7, at 30°C in 1000 ml of LB-amp
medium. Cells harvested by centrifugation at 5000 rpm, 10 min, 4°C were either frozen in
liquid nitrogen or resuspended in 1/20 of volume of lysis buffer (10 mM piperazine, pH
11.0, 1% Triton X-100).
7.3.2. Purification of recombinant plectin repeat domains
Disruption of the cells was performed by incubation with lysozyme (0.1 mg/ml) for 30 min
followed by sonication (Bandolin Sonopuls). The procedure was repeated twice keeping the
cells on ice and then lysates were centrifuged at 12000 rpm, 30 min, 4°C prior to next
purification procedures. His-tagged recombinant proteins were then affinity-purified on
ÄKTA FPLC™ using 5ml HisTrap HP columns following the protocol of the manufacturer,
using the binding, washing, and elution column buffers (20 mM Tris-HCl, pH 9.0, containing
5, 20, and 500 mM imidazole, respectively). Only purification of R4-5 was followed then by
ion-exchange chromatography on 15 ml Source 30Q column; after loading sample column
was washed (20 mM Tris-HCl, pH 9.0) and protein eluted with a 0-2 M NaCl. Gel filtration
on HiLoad Superdex 75 column (20 mM Tris-HCl, pH 9.0, 150 mM NaCl) was used as a
last purification step. Proteins were kept in elution buffer at 4ºC, and dialyzed against the
required buffer prior to be assayed.
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7.3.3. Purification of recombinant full length vimentin
Recombinant full length mouse vimentin was purified by sequential ion-exchange column
chromatography on Q-sepharose and S-sepharose (ÄKTA FPLC™) as described previously
(Nagai and Thogersen, 1987). Following expression, bacterial cell pellets were resuspended
in 1/20 volume lysis buffer (5 mM Tris-HCl, pH 7.5, 1 mM EDTA), incubated with lysozyme
(10 µg/ml, 30 min) and disrupted in a dounce homogenizer. MnCl2 (1 mM), MgCl2 (10
mM) and DNase I (10 µg/ml) were added to the cell suspension to digest the DNA. This
mixture was incubated 30 min at room temperature, then 4 volumes of detergent buffer (20
mM Tris-HCl, pH 7.5, 200 mM NaCl, 1% Deoxycholic acid, 1% Nonidet P40) was added,
and finally the suspension was centrifuged (7500 rpm, 10 min, 4°C). The recovered pellet
was dissolved in 15 ml binding buffer (9 M Urea, 5 mM Tris-HCl, pH 7.5, 1 mM EDTA,
0.4 mM PMSF, 0.1% ß-ME) and centrifuged again (19000 rpm, 15 min, 8°C). The
supernatant was then used for ion-exchange chromatography on 15 ml Q-Sepharose column
using ÄKTA FPLC™. The column was washed with Q-sepharose column buffer (8 M Urea,
5 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.4 mM PMSF, 10 mM ß-ME) and the protein eluted
with a 0-0.5 M NaCl gradient. Fractions with the highest protein concentration were
combined, diluted with 7 volumes of SP-Sepharose column buffer (8 M Urea, 50 mM Na-
formate, pH 4.0, 0.4 mM PMSF, 10 mM ß-ME), and loaded onto 15 ml SP-Sepharose
column. The column was washed with 5 volumes of SP-Sepharose column buffer and eluted
with a 0-0.5 M KCl gradient. Purified vimentin was kept in elution buffer at 4ºC, and
dialyzed stepwise against the required buffer prior to be assayed. All proteins were analyzed
by SDS-PAGE and concentrations were estimated by the Bradford or the bicinchoninic acid
(BCA) method (Pierce).
7.3.4. Determination of protein concentration
Bradford method: Protein content of samples was measured with Bradford Reagent (100 mg
Coomassie G-250 dissolved in 50 ml ethanol, followed by addition of 100 ml 85% H3PO4,
and distilled water to 1000 ml). Protein samples were mixed with the Bradford Reagent and
incubated for 5 minutes at room temperature. Subsequently absorbance was measured at 595
nm. Concentrations of protein samples were calculated using a bovine serum albumin (BSA)
standard curve.
Bicinchoninic acid (BCA) method: BCA reagent mix was prepared immediately
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before use by mixing BCA-reagent A with BCA-reagent B (Pierce) in a 50:1 ratio. 50 µl of
protein sample were added to 1 ml BCA reagent mix, and incubated for 30 minutes at 37°C.
The samples were cooled to room temperature and absorbance at 562 nm was measured.
The protein concentration was calculated from standard curve.
7.3.5. Crystallization of plectin repeat domains
The purified proteins were dialyzed against 20 mM Tris-HCl, pH 9.0 and concentrated to 10
or 20 mg/ml for crystallization. Crystallization trials were performed at 4 and 20 °C using
the sitting- and hanging-drop vapor diffusion method (McPherson, 1982). Drops were
prepared by mixing 1 µl protein solution prepared as described above with 1 µl reservoir
solution. The initial screenings for crystallization conditions was performed using the Crystal
Screens from Hampton Research and JBScreens from Jena BioScience.
7.3.6. SDS-PAGE and immunoblotting
Protein samples (10 µg in 20 µl) were analyzed by SDS-10% PAGE under reducing and
nonreducing conditions. The reduction of samples before application to the gel was achieved
by addition of 0.2 M dithiothreitol (DTT) to 2x sample buffer. After electrophoresis, the gels
were stained with Coomassie Blue (0.25% Coomassie Brilliant Blue, 45% methanol, 10%
acetic acid) and scanned in HP ScanJet 8250. Densitometric analysis was performed with the
Gel Doc 2000 (Bio-Rad Laboratories) gel documentation system and the QuantityOne image
analysis software (Bio-Rad Laboratories).
Transfer to nitrocellulose membranes (Schleicher & Schuell, Portan® 0.2 µm) and
immunoblotting were done using standard procedures. Following electrophoretic transfer of
proteins to nitrocellulose, the membranes were blocked for 60 minutes with 5% milk powder
in phosphate-buffered saline containing 0.05% Tween (PBST), incubated with primary
antibodies diluted in PBST for 60 minutes, washed extensively in PBST, and then incubated
with peroxidase-coupled secondary antibodies for 60 minutes. For detection of immuno-
reactive bands, the Super Signal System (Pierce) was used. Signal intensities were quantified
using the program Quantiscan.
7.3.7. Oxidative cross-linking
For oxidative cross-linking of plectin repeats, purified recombinant proteins at a
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concentration of 0.5 mg/ml were dialyzed against 10 mM Tris-HCl, pH 7.9, overnight at
4°C, while concurrently exposed to oxidation by air. The reaction was quenched by addition
of iodoacetamide (final concentration 50 mM) to block free sulfhydryl groups. Samples were
then resolved by SDS-10% PAGE under nonreducing or reducing conditions. Alternatively,
aliquots of two different recombinant proteins were mixed 1:1 at a concentration of 0.5
mg/ml each, dialyzed against 10 mM Tris-HCl, pH 7.9, 6 M urea, and 1 mM DTT, for 1.5
h at room temperature, and subsequently oxidized by air while dialyzed at 4°C into 10 mM
Tris-HCl, pH 7.9, without urea. The reactions were then quenched and analyzed as described
above.
For oxidative cross-linking of plectin repeat 5 domain and vimentin, polymerized
vimentin was incubated with His-tagged plectin R5 wt, or R5 Cys-free, and then oxidized
by 100 µM SNAP for 2 hours. Samples were dissolved in gel loading buffer supplemented
with 6M urea, subjected to SDS-10% PAGE under nonreducing conditions, and immuno-
blotted using anti-His-tag or anti-vimentin antibodies.
7.3.8. Europium overlay binding assay
Recombinant vimentin was dialyzed stepwise against 50 mM NaHCO3, pH 8.5, and labeled
with Eu3+ overnight at room temperature, using 10 µl of Eu3+-labeling reagent per 100 µl of
protein samples (0.5-1.5 mg/ml) according to the protocol of the manufacturer (Wallac,
Turku, Finland). When vimentin was labeled with Eu3+, it was subsequently Cdk1-
phosphorylated in some samples as described later. For binding assays, 96-well microtiter
plates were coated (overnight at 4°C) with 100 µl of 100 nM recombinant non-
phosphorylated or Cdk1-phosphorylated plectin R5-6, or BSA type H1 (Gerbu Biotechnik,
Gaiberg, Germany), all in 25 mM Na2B4O7, pH 9.3. Coating was followed by blocking with
4% BSA in PBS, for 1 hour at room temperature. After washing with PBS, plates were
overlaid with dilutions of Eu3+- labeled proteins (10-500 nM) in 100 µl of PBS, 1 mM
EGTA, 2 mM MgCl2, 1 mM DTT, and 0.1% Tween 20, for 90 minutes at room temperature.
Plates were washed six times with PBS, and protein bound was then determined by releasing
the complexed Eu3+ with enhancement solution and measuring fluorescence with a Delfia
time-resolved fluorometer (Wallac; excitation wavelength 340 nm, emission wavelength 615
nm). Further details of this assay have previously been described (Nikolic et al., 1996;
Steinböck et al., 2000). The Scatchard method was used for analysis of binding data and
Figure 4. Schematic diagram of the Biotin switch
assay for the detection of the S-nitrosylated
proteins. A protein is indicated with cysteines in
the free thiol, disulfide or nitrosothiol form. In
the first step of this assay free thiols are blocked
by methylthiolation with MMTS, and this
modification can be reversed by β-ME reduction.
Remaining MMTS is then removed in the next
step either by acetone precipitation of protein
mixture or by passing through the spin column.
In the final step nitrosothiols are selectively
reduced by the ascorbate to thiols form, which
are then biotinylated by biotin-HPDP. Note that
biotinylated proteins could be detected directly
with antibodies or recovered by streptavidin-
affinity chromatography (Jaffrey and Snyder,
2001).
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fluorescence values converted to concentrations by comparison with a Eu3+ standard.
7.3.9. S-nitrosylation biotin-switch assay
S-nitrosylated proteins were detected using the biotin-switch assay as described by Jaffrey
and Snyder (Jaffrey and Snyder, 2001). For in vitro assays purified R5 wt and R5-C4S (80
µg each) in 250 mM HEPES, pH 7.7, 1 mM EDTA, 0.1 mM neocuproine (HEN solution)
were incubated in the dark with 100 µM SNAP for 2 h at room temperature, and the NO
donors were then removed by passing the samples twice through a desalting column (Micro
BioSpin P6, BioRad). Proteins in the flowthrough were blocked with 20 mM methyl
methanethio-sulfonate (MMTS, Sigma) for 20 min at 50ºC, precipitated with acetone for 20
min at -20ºC, and collected by centrifugation at 10,000xg for 10 min at 4ºC. Pellets were
resuspended in 500 µl HENS (HEN solution containing 1% SDS), and incubated with 1 mM
ascorbic acid to release NO from thiol groups, which were subsequently biotinylated with 1
mM biotin-HPDP (Pierce). Proteins were again acetone-precipitated, resuspended in 300 µl
HENS solution, and biotinylated proteins recovered by streptavidin-affinity chromatography.
Eluted proteins were separated by SDS–10% PAGE, transferred to nitrocellulose membranes
and analyzed by immunoblotting using antibodies and visualized by chemiluminescence.
For the identification of S-nitrosylated proteins in cultured cells, confluent mouse
renal endothelial cells (~2.5x107) were incubated with 100 µM SNAP for 2 h in the dark, or
with 100 nM PMA for 20 h, washed thoroughly with PBS, scraped off, and lysed in 350 µl
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HEN solution supplemented with 2.5% SDS, blocked with MMTS, and subjected to the
biotin-switch assay as described above.
7.3.10. Phosphorylation of proteins by Cdk1
10 µg of the proteins (plectin R5-6 or vimentin) were resuspended in 20 mM Tris-HCl, pH
7.4, 100 mM MgCl2, 1 mM EGTA, 1 mM NaF, and 0.1 mM ATP, and incubated (30 min at
37°C) with 1 unit of recombinant Cdk1/cyclinB (Vermeulen et al., 2002), kindly provided
by V. Krystof (Palacky University, Olomouc, Czech Republic). The reaction was stopped by
adding EDTA to a final concentration of 10 mM.
7.3.11. IFs assembly in vitro
To prepare filaments, recombinant vimentin was dialyzed stepwise at room temperature
against 5 mM Tris-acetate, pH 8.3, 1 mM EDTA, and 10 mM β-ME, with decreasing
concentrations of urea (6-0 M). The dialyzed vimentin solution was centrifuged in a
Beckmann benchtop ultracentrifuge (OptimaTM TLX) at 100,000xg for 30 min at room
temperature. Soluble non-phosphorylated or Cdk1-phosphorylated vimentin was mixed with
(either unphosphorylated or phosphorylated) plectin domain R5-6 at different concentrations
(molar ratios of vimentin:plectin 1:1-10:1) and polymerized in 20 mM HEPES, pH 7.5, 150
mM NaCl, 1 mM EDTA, and 0.1% (v/v) Tween-20, for 1 h at 37°C.
7.3.12. Electron microscopy
For staining with uranyl acetate, 7 µl of protein samples (final concentrations 10 µM) were
loaded onto Formvar/carbon-coated and glow-discharged 400 mesh-copper grids and stained
8 times (40 s each) with 1% uranyl acetate. Specimens were visualized in a JEOL 1210
electron microscope operated at 80 kV.
7.4. Mammalian cell culture
7.4.1. Cell culture
The immortalized endothelial cell line used in this study was generated by Kerstin Andrä
Marobela. Primary mouse kidney endothelial cells isolated by standard procedures from
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wild-type and plectin-/- neonatal (1 day old) mice were transduced with a polyoma middle T
(PymT)-expressing retrovirus that confers growth advantage to endothelial cells over other
types of cells (Williams et al., 1988). The kidneys from one mouse were excised, rinsed 3x
with PBS, minced, and digested with 0.1 mg/ml collagenase (type XI, Sigma) for 30 min
with gentle shaking at 37ºC in 5 ml DMEM. After centrifugation, the cell pellet was
resuspended in DMEM supplemented with 10% heat-inactivated fetal calf serum and seeded
onto two 9.6 cm2 0.2% gelatin-coated plates (2 wells of a 6 well plate). Two days later the
cell monolayers were infected with PymT as described previously (Golenhofen et al., 2002).
In brief, after a 2 h exposure to the virus, the medium was exchanged, cells were cultured
for 48 h and then selected with G418 (0.8 µg/ml). Stable cell lines were obtained 4-5 weeks
later. Cultures were subsequently expanded and characterized for several endothelial marker
proteins such as von Willebrand factor, VE-cadherin, and PECAM-1 (CD31). Cells were
negative for cytokeratins, GFAP, and the tight junction protein zona occludens 1 (ZO-1).
Immortalized cells lines were routinely maintained on gelatin (Spurny et al., 2007).
Immortalized mouse dermal fibroblasts were derived from plectin+/+/p53-/- (wild-type)
and plectin-/-/p53-/- (knockout) mice as previously described (Andrä et al., 2003). Primary
cells were derived in a similar manner from plectin+/+ and plectin-/- mice. Experiments with
immortalized cells were performed with cells from passages 8 to 15 after isolation. Cells
were grown at 37°C in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
calf serum. Confluent cultures grown on plastic dishes were trypsinized, dispersed into
culture medium, and the cells replated onto coverslips at densities of 104-105/cm2 (Prahlad
et al., 1998).
7.4.2. Preparation of cell lysates
Confluent cells were washed twice with phosphate-buffered saline. Cells were lysed directly
with 50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromphenol blue, 10% glycerol
(sample buffer). Aliquots of cell lysates containing equal amounts of total proteins were
separated by SDS 5% PAGE and, after immunoblotting protein bands were visualized by
exposure to x-ray film as described above.
7.4.3. NO donor mediated nitrosylation of endothelial cells
Endothelial cells were grown on gelatin-coated glass coverslips, treated with NO donor-
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mediated nitrosylation 100 µM SNAP in the dark for 2, 4, or 6 h, washed with PBS, and then
fixed with cold methanol at -20°C for 90 sec prior to processing for immunofluorescence
microscopy (Gregor et al., 2006). After incubation with primary and secondary antibodies,
specimens were viewed in a Zeiss Axiophot fluorescence microscope and confocal images
were obtained using an LSM 510 module (Carl Zeiss).
7.4.4. Spectrofluorimetric determination of NO released from endothelial cells
NO release by endothelial cells was measured using the DAF-2 fluorescence assay, as
described previously (Leikert et al., 2001; Rathel et al., 2003). Endothelial cells were grown
until confluence and for selected experiments stimulated with protein kinase A activator
PMA (100 nM) for 20 hours. Cells were washed twice with PBS containing arginine (100
µM) and incubated with 2 ml of this buffer with or without the irreversible eNOS inhibitor
L-NAA (200 µM). After 10 minutes of equilibration at 37°C, the NO-sensitive fluorescent
probe DAF-2 as well as calcium ionophore A23187 were added into the buffer. Following
another 30 minutes of incubation at 37°C, the supernatant was taken off into reaction tubes,
cells were washed with 1 ml of ice cold PBS, and stored at 4°C until further processing.
Fluorescence was measured in quartz cuvettes at 515 nm (excitation: 492 nm) in a Shimadzu
fluorometer. Then the cells were trypsinized and counted automatically in a ViCell cell
counter (Beckman Coulter). Fluorescence units were normalized to the number of cells.
7.4.5. Synchronization by double thymidine block
Fibroblast cell synchronization was performed by double thymidine block followed by
nocodazole treatment. For the first block, exponentially growing cells were incubated with
2 mM thymidine for 16 h. This was followed by a 9-h release in which cells were washed
and incubated in fresh medium, and a second block for another 16 h. Cells were then washed
and cultivated for an additional 24 h in growth medium containing 400 ng/ml nocodazole.
Mitotic cells that rounded up and detached from the petri dish were harvested by mechanical
shake-off (Merrill, 1998), washed thoroughly to remove nocodazole, replated on polylysine-
coated glass coverslips and then incubated at 37°C to allow for cell cycle progression. At
different time intervals, cells were fixed in 4% formaldehyde and processed for immuno-
fluorescence microscopy.
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7.4.6. Immunofluorescence microscopy
Endothelial cells grown on gelatin-coated glass coverslips in DMEM supplemented with
10% fetal calf serum and a standard complement of antibiotics were rinsed rapidly in PBS,
and fixed in methanol for 90 seconds at -20°C. Fibroblasts, plated on glass coverslips, were
fixed in 100 mM Pipes, 2 mM EGTA, 1 mM MgSO4, pH 6.9 (PEM), supplemented with 4%
formaldehyde for 6 min at room temperature; after fixation, cells were permeabilized in
0.1% NP-40 in PEM for 3 min at room temperature, and then briefly washed in PEM for 3
min. BSA (5%) was added to the fixed cells to block non-specific binding sites, and cells
were then washed five times for 5 minutes with PBS. Samples were incubated with primary
antibodies for 1 hour at room temperature. Coverslips were then washed thoroughly with
PBS, incubated with secondary antibodies for 1 hour at room temperature, washed again
with PBS, and finally rinsed with water and mounted in mowiol. For actin-staining,
phalloidin-Texas Red (dilution 1:150) was used in the mixture with secondary antibodies.
Specimens were viewed in a Zeiss Axiophot fluorescence microscope and confocal images
were obtained using an LSM 510 module (Carl Zeiss).
7.4.7. Cell transfection
For live cell observations, a cDNA construct (pMG3) encoding GFP-tagged vimentin was
transfected into wild-type and plectin-null fibroblasts using Fugene (Roche Applied Science)
following the instructions of the manufacturer. Briefly, 6 µl Fugene reagent was incubated
with 100 µl of serum free DMEM and 2 µg DNA for 30 minutes at room temperature. Then
an appropriate volume (final volume 50 µl) of Opti-MEM was added, and this mix was
subsequentially added to the medium of a sub-confluent cell culture (culture dish 5 cm in
diameter). After 24-48 h of transfection, cells were trypsinized and replated onto glass
coverslips for live cell observations.
7.4.8. Live-cell imaging
Time-lapse video microscopy was implemented on a Zeiss Axiovert S100TV microscope
equipped with phase-contrast and epi-illumination optics. Cells were spread on glass
coverslips at a density of 2.8×105 cells/cm2 and kept in phenol red-free DMEM during the
whole period of observation. Cells were monitored in a closed POCmini cultivation system
(Carl Zeiss MicroImaging, Inc) under 5% CO2 and at 37°C. Recordings of squiggle motility
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started 14 h after plating, and frames were taken with a 100x lens in 10-sec intervals over
a period of 15 min. Images were obtained using a back-illuminated, cooled charge-coupled
device camera (Princeton Research Instruments) driven by a 16-bit controller. The whole
video microscopy system was automated by Metamorph 6.3 (Universal Imaging Corpo-
ration). The length of trajectories of moving squiggles was measured by tracking their ends.
For statistical evaluation 20–30 squiggles per genotype were monitored.
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Immunoblotting
Primary
antibody (Anti-)
Source Dilution
Secondary
antibody
Source Dilution
Plectin #46
Andrä et al.,
2003
1:4000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:50,000
Plectin #9
Andrä et al.,
2003
1:2500
goat anti-rabbit
HRPO
Jackson
Laboratories
1:50,000
Plectin 10F6
Foisner et al.,
1994
1:100
goat anti-mouse
HRPO
Jackson
Laboratories
1:50,000
Plectin exon 1
Abrahamsberg
et al., 2005
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:30,000
Plectin exon 1f
Abrahamsberg
et al., 2005
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:30,000
Vimentin
Giese and
Traub, 1986
1:10,000
donkey anti-goat
HRPO
Jackson
Laboratories
1:50,000
Actin
A-2066;
Sigma-Aldrich
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:30,000
HIS tag
34660; Qiagen
Inc.
1:1000
goat anti-mouse
HRPO
Jackson
Laboratories
1:20,000
eNOS
610297; BD
Trans. Lab.
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:20,000
eNOS Thr495
9574; Cell
Signaling
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:20,000
eNOS Ser1177
9571; Cell
Signaling
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:20,000
Akt
9272; Cell
Signaling
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:20,000
Akt Ser473
9271; Cell
Signaling
1:1000
goat anti-rabbit
HRPO
Jackson
Laboratories
1:20,000
7.5. Antibodies
Lists of antibodies used for immunoblotting (A) and immunofluorescence microscopy (B):
A
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Immunofluorescence microscopy
Primary
antibody (Anti-)
Source Dilution
Secondary
antibody
Source Dilution
Plectin #46
Andrä et al.,
2003
1:500
Cy5 donkey
anti-rabbit
Jackson
Laboratories
1:1000
Plectin 10F6
Foisner et al.,
1994
1:2
RRX donkey
anti-mouse
Jackson
Laboratories
1:1000
Plectin exon 1
Abrahamsberg
et al., 2005
1:1000
Cy5 donkey
anti-rabbit
Jackson
Laboratories
1:1000
Plectin exon 1f
Abrahamsberg
et al., 2005
1:50
Cy5 donkey
anti-rabbit
Jackson
Laboratories
1:1000
Vimentin
Giese and
Traub, 1986
1:1000
Cy2 donkey
anti-goat
Jackson
Laboratories
1:1000
α-Tubulin
B-512;
Sigma-Aldrich
1:1000
RRX donkey
anti-mouse
Jackson
Laboratories
1:1000
eNOS
610297; BD
Trans. Lab.
1:1000
CY5 donkey
anti-rabbit
Jackson
Laboratories
1:1000
Vinculin
V-4505;
Sigma-Aldrich
1:100
RRX donkey
anti-mouse
Jackson
Laboratories
1:1000
B
8. RESULTS
The results are organized into three parts. The first part focuses on the purification and
crystallization of plectin fragments containing the IF-binding site. The second part describes
the effects of cysteine oxidation on vimentin-binding of plectin and on intra- and inter-repeat
disulfide bridge formation of the plectin molecule. It also describes nitrosylation of plectin’s
cysteines and its involvement in IF collapse. The third part describes the effects of plectin
phosphorylation on vimentin-binding and on IF network formation and dynamics.
8.1. PURIFICATION AND CRYSTALLIZATION OF PROTEINS
To crystallize plectin fragments containing the IF-binding site, to study the vimentin-binding
to plectin, to study the disulfide bridges formation and nitrosylation in vitro, and to study IF
architecture, several recombinant proteins were purified. Originally most of the purification
procedures were developed for crystallography. As the information gained in these studies
could be useful for future research on the structure of plectin molecules, the first part of
Results is entirely devoted to the description of these procedures.
8.1.1. Expression and purification
Since full-length plectin (>500 kDa) or even entire subdomains, such as the C-terminal
globular domain with its six repeat domains (>200 kDa) are too large to be recombinantly
expressed for biochemical analyses, our study was restricted to single plectin repeat domains
or combinations of two repeat domains.
To assess the potential of individual repeat 5 domain cysteines to form disulfide
bridges, recombinant versions of the repeat 5 domain were used (K. Abdoulrahman, PhD
Thesis, 2004), where all four cysteines were replaced by serines, either individually, or in
different combinations. Cys1 and Cys4 were mutated alone and in various combinations
with Cys2 and Cys3, including a mutant without any cysteine (R5 Cys-free). In addition, a
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mutant with native Cys1 and Cys4, but without Cys2 and Cys3 (R5-C2S, C3S) and its
counterpiece with Cys2 and Cys3, but without Cys1 and Cys4 (R5-C1S, C4S) were used
(K. Abdoulrahman, PhD Thesis, 2004). Schematics of R5 wt and the eight mutant versions
used and their assigned names are shown in Fig. 5. In addition to the single repeat 5 domain,
protein fragments consisting of two repeat domains were used. Fragment R4-5 contained
the repeat 4 domain linked to the repeat 5 domain and the following linker domain
containing the IF-binding site. Fragment R5-6 contained repeats 5 and 6 connected by their
linker domain (containing the IF-binding site), and R5-6tail resembled R5-6 but contained
also the terminal tail region.
R5 wt
The wild-type version of plectin’s R5 domain which was quite soluble was purified using
nickel ion affinity chromatography (Fig. 6A). After loading the sample onto the column and
washing, by which a fair amount of protein impurities were removed, the protein bound was
eluted with 0.5 M imidazole. The fractions corresponding to the protein peaks in the
chromatogram were analyzed by SDS–PAGE. As shown in Fig. 6B, fractions B9–B13
contained high concentrations of a protein with an apparent molecular mass of ~41 kDa.
Homogeneity of the eluted protein was further tested using size exclusion chromatography,
where a single peak was observed (Fig. 6C), showing that the protein was homogeneous
and formed just one conformation.
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Cys1 Cys2Cys3 Cys4
R5 wt
R5-C1S
R5-C4S
R5-C1S,C2S
R5-C1S,C3S
R5-C2S,C3S
R5-C1S,C4S
R5-C1S,C2S,C3S
R5 Cys-free
Figure 5. Schematic representation of wild-type and mutated versions of the repeat 5 domain used in this study.
The name of each mutant is indicated on the left hand side. Mutants are named according to the numbers of the mu-
tated cysteines; wt, wild-type. Only cysteine residues (open ellipsoids) and their serine replacements (filled ellip-
soids) are shown. Cysteine residues Cys1-4 of repeat 5 domain correspond to residues 4074, 4248, 4257, and 4316
in full length plectin (SwissProt accession number P30427).
R5 Cys-free
Standard purification procedure used for R5 wt resulted in low solubility and yields of R5
Cys-free, therefore purification of this particular protein was modified. After cells lysis and
centrifugation, most of the R5 Cys-free protein was present in the pellet in an insoluble
form. Protein pellets were solubilized by increasing the pH of the solution to 11. By this
treatment most of the protein was solubilized and could then be subjected to HisTrap affinity
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Figure 6. Purification of plectin fragment R5 wt by affinity chromatography. (A) Elution profile of R5 wt from a
HisTrap column using the ÄKTA FPLC™ system. Pure protein was eluted from the column by 500 mM imidazole
and fractions with the highest absorbance were collected. Grey colored area corresponds to fractions containing
eluted R5 wt. Blue (UV), absorbance of the sample; green, concentration of eluent; brown, conductivity; red,
fractions.(B) 10% SDS-PAGE (Coomasie staining). Lanes correspond to indicated fractions in A; lane X1 represents
unbound proteins in fraction X1, lane A5 corresponds to proteins contained in one of the fractions collected during
the washing step, and lanes B9-C1 correspond to eluted fractions. (C) Size exclusion chromatography on a HiLoad
Superdex 75 column. Note, the single peak indicated that the protein existed in a single conformation.
column chromatography (Fig. 7A). The purification procedure was then continued in the
same way like in the case of R5 wt. This one-step affinity chromatography purification
yielded protein of greater than 90% purity (Fig. 7B). Homogeneity of the R5 Cys-free sample
was confirmed by size exclusion chromatography (Fig. 7C).
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Figure 7. Purification of plectin fragment R5 Cys-free by affinity chromatography. (A) Elution profile of R5 Cys-
free from a HisTrap column using the ÄKTA FPLC™ system. Pure protein was eluted from the column by 500 mM
imidazole and fractions with the highest absorbance were collected. Grey colored area corresponds to fractions
containing eluted R5 Cys-free. Blue (UV), absorbance of the sample; green, concentration of eluent; brown,
conductivity; red, fractions. (B) 10% SDS-PAGE (Coomasie staining). Lanes correspond to indicated fractions in
A; lane X1 represents unbound proteins in fraction X1, lane X4 corresponds to proteins contained in one of the
fractions collected during the washing step, and lanes A1-A5 correspond to eluted fractions. (C) Size exclusion
chromatography on a HiLoad Superdex 75 column. Note, the single peak indicated that the protein existed in a single
conformation.
All other recombinant versions of the repeat 5 domain where cysteines were replaced,
(either individually or in different combinations) by serines, were expressed to an extent
similar to that of R5 wt and displayed similar solubilities. They, too, were purified by one-
step affinity chromatography on a HisTrap column, as described in detail in Materials and
Methods.
R4-5
In purifying R4-5 by affinity chromatography on a HisTrap column, the washing steps
removed most of the protein impurities (Fig. 8A). However, the purity of eluted R4-5 was
still insufficient. Therefore two additional purification steps were performed, one of which
was ion-exchange chromatography using a SourceQ column, where R4-5 mostly eluted at
250 mM NaCl (Fig. 8B). Peak fractions from the ion-exchange chromatography were
collected and subjected to gel filtration on a Superdex column. R4-5 eluting as a single major
peak was homogeneous as verified by SDS-PAGE (Fig. 8C).
R5-6 and R5-6tail
To purify R5-6 and R5-6tail one-step purification schemes using nickel ion affinity
chromatography were applied (Figs. 9A and 10A). Both proteins were expressed to a similar
extent and were of similar solubility, as assessed by SDS-PAGE (Fig. 9B and Fig. 10B) and
gel filtration chromatography (Fig. 9C and Fig. 10C).
Recombinant vimentin
Recombinant full-length (untagged) vimentin was purified in two steps by ion-exchange
chromatography as described previously (Nagai and Thogersen, 1987). After the first step
(anion-exchange purification on Q-sepharose columns, Fig. 11A), eluted protein peaks were
analyzed by SDS-PAGE and fractions of highest purity were used for cation-exchange
chromatography on SP-sepharose columns (Fig. 11B). The purity of salt-eluted vimentin
protein samples was verified by SDS-PAGE and in vitro assembly of IFs (shown in part 7.3.
of Results, Fig. 26 A).
48
49
Figure 8. Purification of plectin fragment R4-5 by a three-step purification. Elution profiles of R4-5 from affinity
HisTrap (A), ion exchange Source Q (B), and gel filtration Superdex 75 (C) columns using the ÄKTA FPLC™
system. Protein corresponded to R4-5 eluted from the columns and fractions with the highest absorbance were
collected. Grey colored area corresponds to fractions containing eluted R4-5. Blue (UV), absorbance of the sample;
green, concentration of eluent; brown, conductivity; red, fractions. 10% SDS-PAGE (Coomasie staining): Lanes
correspond to indicated fractions in chromatogram.
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Figure 9. Purification of plectin fragment R5-6 by affinity chromatography. (A) Elution profile of R5-6 from a
HisTrap column using the ÄKTA FPLC™ system. Pure protein was eluted from the column by 500 mM imidazole
and fractions with the highest absorbance were collected. Grey colored area corresponds to fractions containing
eluted R5-6. Blue (UV), absorbance of the sample; green, concentration of eluent; brown, conductivity; red, frac-
tions.(B) 10% SDS-PAGE (Coomasie staining). Lanes correspond to indicated fractions in A; lane X1 represents
unbound proteins in fraction X1, lane A4 corresponds to proteins contained in one of the fractions collected dur-
ing the washing step, and lanes B8-C1 correspond to eluted fractions. (C) Size exclusion chromatography on a
HiLoad Superdex 75 column. Note, the single peak indicated that the protein existed in a single conformation.
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Figure 10. Purification of plectin fragment R5-6tail by affinity chromatography. (A) Elution profile of R5-6tail from
a HisTrap column using the ÄKTA FPLC™ system. Pure protein was eluted from the column by 500 mM imida-
zole and fractions with the highest absorbance were collected. Grey colored area corresponds to fractions contain-
ing eluted R5-6tail. Blue (UV), absorbance of the sample; green, concentration of eluent; brown, conductivity; red,
fractions.(B) 10% SDS-PAGE (Coomasie staining). Lanes correspond to indicated fractions in A; lane X1 repre-
sents unbound proteins in fraction X1, lane A3 corresponds to proteins contained in one of the fractions collected
during the washing step, and lanes B8-C1 correspond to eluted fractions. (C) Size exclusion chromatography on a
HiLoad Superdex 75 column. Note, the single peak indicated that the protein existed in a single conformation.
52
Figure 11. Purification of recombinant vimentin by a two-step purification. Elution profiles of vimentin from an
anion-exchange Q-sepharose (A) and cation-exchange SP-sepharose (B) columns using the ÄKTA FPLC™ sys-
tem. Protein corresponded to vimentin eluted from the columns and fractions with the highest absorbance were
collected. Grey colored area corresponds to fractions containing eluted vimentin. Blue (UV), absorbance of the
sample; green, concentration of eluent; brown, conductivity; red, fractions. 10% SDS-PAGE (Coomasie stain-
ing). Lanes correspond to indicated fractions in chromatogram.
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8.1.2. Crystallization
In the course of my thesis I attempted to crystallize the following plectin constructs: R5 wt,
R5 Cys-free, R4-5, R5-6 and R5-6tail. Purified protein samples were concentrated to ~10
mg/ml and centrifuged prior to crystallization assays. Crystallization trials were performed
by hanging and sitting drop vapour diffusion. Of all the samples tested only plectin R5 Cys-
free and R4-5 were forming crystals.
R5 Cys-free
Crystallization screening, consisting of more than thousand different solutions, varying
mostly in pH and concentration of the precipitant, resulted in mostly amorphous precipitates
or phase separation. After approximately 14 days, small, clustered, needle-shaped crystals
occurred in 0.2 M MgCl2, 0.1 M Tris-HCl, pH 8.5, 15% PEG 4000 (Fig. 12A). In order to
obtain crystals with appropriate dimensions I tried to optimize the conditions for crystalli-
zation by employing a process called macroseeding. For this method the clustered needle
crystals were broken to single crystals and to avoid crystal bending, the longer needle
crystals were further split into shorter fragments. Unfortunately, macroseeding again resulted
in the formation of only small clustered needle crystals. I then tried to optimize
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Figure 12. Clustered needle-shaped crystals of R5 Cys-
free grown in the 0.2 M MgCl2, 0.1 M Tris-HCl, pH 8.5,
15% PEG 4000 (A); rod-shaped crystal grown in 0.2 M
NaF, 20% PEG 3350 (B); and clustered crystal grown in
20% PEG 3000, 0.1 M Tris-HCl pH, 7.0, and 0.2M
Ca(OAc)2 (C). Bar, 0.2 mm.
crystallization by employing conditions varying only slightly from those of the initial
successful crystallization attempt. In particular, I varied the pH and the concentrations of
MgCl2 and PEG. However, R5 Cys-free continued to form amorphous precipitates or
clustered needle-shaped crystals. Also, when a screening with detergents as additives was
carried out, in the presence of 0.2 mM sucrose monolaurate or 2.5 mM n-decanoylsucrose,
only the formation of small clustered needle crystals was observed.
Two other conditions (0.2 M NaF and 20% PEG 3350; and 20% PEG 3000, 0.1 M
Tris-HCl pH 7.0, and 0.2M Ca(OAc)2) gave rise to minuscule crystals, smaller than 0.05 mm
in size (Fig 12B and C, respectively), without any increase in size over time. To obtain larger
crystals, again I tried to optimize the conditions for crystallization by varying the pH and the
concentrations of salt and PEG, as well as by adding detergents. Unfortunately none of these
conditions resulted in formation of aptly bigger crystals.
R4-5
Within approx. 14 days of the crystallization trials, R4-5 yielded very small crystals (Fig.
13A), or clustered needle-shaped crystals (Fig. 13B), in several drops containing PEGs of
different molecular weights and/or different concentrations. Figs. 13A and B show examples
in 20 mM Tris-HCl, pH 9.0, 20% PEG 20K, and sucrose monolaurate; and 20 mM Tris-
HCl, pH 9.0, 10% PEG 1000, and sucrose monolaurate, respectively. However, optimization
attempts of crystallization through modification of the pH, the concentration of PEGs, the
addition of detergent, or the macroseeding of needle crystals did not result in improved
crystals with appropriate dimensions suitable for the collection of X-ray diffraction data.
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Figure 13. Very small crystals of R4-5 grown in 0.2 M MgCl2, 0.1 M Tris-HCl, pH 8.5, 15% PEG 4000 (A) and
clustered needle-shaped crystals grown in 0.2 M NaF, 20% PEG 3350, 20% PEG 3000, and 0.1 M Tris-HCl, pH
7.0, 0.2M Ca(OAc)2 (B). Bar, 0.3 mm.
8.2. NITROSYLATION OF PLECTIN: EFFECTS ON VIMENTIN-
BINDING AND INVOLVEMENT IN IF COLLAPSE
8.2.1. Structure prediction for plectin repeats and implications for
cysteine residue exposure
The C-terminal repeat domains of plakin protein family members have been classified as
type A, B, and C (Green et al., 1992). Desmoplakin has three such domains (one of each
type), while five of the six plectin repeat domains are of the B-type (repeat domains 1-5) and
one of the C-type (repeat domain 6) (Wiche et al., 1991). Within the repeat regions, plectin
and desmoplakin share a high sequence similarity and all but one of the cysteines present in
plectin’s repeat domains 4-6 are present in desmoplakin’s repeat domains A-C. I chose the
repeat 5 domain for structure prediction, which contains four cysteines and one of them
resides in the linker region containing the IF-binding site. As an additional option, I selected
the repeat 1 domain, which contains only one cysteine corresponding to cysteine 2 in repeat
domain 5. This repeat 1 domain also harbors the point mutation E2798K (substitution of
glutamic acid 2798 by lysine), which has been shown to be responsible for skin blistering,
therefore this mutation is likely to affect the package of the repeats.
3D structure of plectin’s repeat 5 domain and localization of cysteines
To gain insight into the location and accessibility of the cysteine residues within the repeat
5 domain, I generated by an automated homology modeling server (SWISS-MODEL,
GENO3D) a 3D model of plectin’s repeat 5 domain based on the recently solved crystal
structure of the desmoplakin B-type repeat domain (Choi et al., 2002; Protein Data bank
1LM7). The alignment of the target (plectin repeat domain 5) and the template (desmo-
plakin’s B domain), obtained using the Needleman-Wunsch global alignment algorithm on
EMBL-EBI server (http:/www.ebi.ac.uk/emboss/align/), is shown in Fig. 14A and C.
The overall topology of the 3D structure of plectin’s repeat 5 domain (Fig. 14B) was
found to be similar to that of the model template, yet small differences are likely to confer
unique properties to plectin. Like desmoplakin’s B-type repeat domain, plectin’s repeat 5
domain comprises 5 homologous copies of a 38 amino acid-long structural subunit, called
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the PLEC repeat (SMART accession number SM00250). Each of the five PLEC repeats
adopts a fold that, similar to the one described for desmoplakin, is dominated by two
antiparallel β-sheets (forming a β-hairpin) and two antiparallel α-helices (Fig. 14, A and B).
The fold is remarkably similar to a structure referred to as ankyrin repeat, as it was predicted
by threading analysis (Janda et al., 2001). Conserved hydrophobic residues in the β-hairpin
contribute to the packing within each PLEC repeat and promote the adoption of a globular,
cylinder-like structure that is 45 Å long with a diameter of 25 Å. Cys1 is located in the β-
hairpin of the first PLEC repeat, while Cys2 and Cys3 are in the terminal part of the fifth
PLEC repeat, which is in close vicinity of the first PLEC repeat (Fig. 14B). Cys2 and Cys3
are on the surface of the structure, whereas Cys1 is partially buried in a groove. The
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Figure 14. Proposed structural model of plectin's repeat 5 domain. (A) Sequence alignment of the template (desmo-
plakin B domain) and plectin’s repeat 5 domain with secondary structure assignments derived from the homology
model. Arrows and ribbons indicate β-strands and α-helices, respectively. Residues in red, green and black are iden-
tical, similar, or different, respectively. Cysteine residues are marked by asterisks. (B) Homology model of plectin's
repeat 5 domain based on the structure of the desmoplakin B-type repeat domain, represented as a ribbon diagram.
PLEC repeats 1-5 are highlighted in red, yellow, blue, orange, and green, respectively. The PLEC fold is charac-
terized by two antiparallel β-sheets that form a β-hairpin and two antiparallel α-helices. Cysteine residues (Cys1-
3) are numbered sequentially according to their position in the polypeptide chain. (C) Sequence alignment of the
linker region connecting repeat domains B and C of desmoplakin and repeat 5 and 6 domains of plectin. The posi-
tion of Cys4 is marked by an asterisk. The nitrosylation consensus sequence is boxed.
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crystallized desmoplakin fragment did not include the linker region containing the
corresponding Cys4. There is evidence, however, that this cysteine, residing in the loop
connecting the B-type with the C-type repeat domains, is exposed, as partial chymotryptic
digestion of the bacterially expressed C-terminal domain of desmoplakin resulted in cleavage
of the polypeptide within this repeat domain linker region (Choi et al., 2002). Secondary
structure predictions for this region suggest that Cys4 is located in a short unstructured
sequence connecting an α-helical segment and a β-sheet (Fig. 14A). This linker region is
also the one of highest sequence conservation amongst different plakin family members
(Määttä et al., 2000). An alignment of the corresponding linker regions of plectin and
desmoplakin is shown in Fig. 14C.
3D structure of plectin’s repeat 1 domain and of plectin mutant E2798K
In order to localize and assess the accessibility of the E2798K mutation within the repeat 1
domain through homology modelling, 3D models of the wild-type and mutant repeat 1
domains were generated, again based on the crystal structure of the human desmoplakin
repeat B domain (Choi et al., 2002). The alignment of plectin’s repeat 1 domain and the
template showed 69% identity and 82% sequence similarity. The 3D model was obtained
with Modeller 8v1 (http://salilab.org/modeller/) and refined using Swiss-Pdb Viewer v3.7
(http://www.expasy.org/spdbv/). The overall topology of the 3D structure of plectin’s repeat
1 domain (Fig. 15A) was found to be very similar to that of the model template as well as
to the predicted model of plectin’s repeat 5 domain (Fig. 14B). The mutation E2798K lies
in the 4th helix of the repeat 1 domain. By superimposing the mutated and the wild-type
forms no differences in the positions of the Cα atoms of both proteins chains were observed
(Fig. 15A). The only detectable alteration was in regard to the secondary structure at the
site of the mutation, as in the mutated form the helix was prolonged by one amino acid
residue (Fig. 15, A and B).
The calculation and the visualization of the electrostatic potential were performed
using the program PyMOL v0.98 (http://pymol.sourceforge.net/). The wild-type repeat 1
domain has a negatively charged glutamic acid at position 2798 and therefore bears a
negative electrostatic potential. In the mutated form the glutamic acid is replaced by lysine
resulting in a large region of positive electrostatic potential (Fig. 15C). The electrostatic
potential of proteins caused by charged side chains plays an important role in protein folding
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Figure 15. Proposed structural model of superimposed plectin's wild-type repeat 1 domain and mutant R1-E2798K.
(A) Homology model of the plectin repeat 1 domain based on the structure of the desmoplakin B-type repeat do-
main represented as a ribbon diagram. The mutation E2798K lies in the 4th helix of the repeat 1 domain. The he-
lices in PLEC repeats 1-5 are indicated as well as the wild-type glutamic acid (Glu) and the mutant lysine (Lys).
(B) Detail of the superposition shown in A. Note, that in the mutated form the helix is prolonged by one amino acid
residue (asterisk). (C) Electrostatic potential of the wild-type repeat 1 and R1-E2798K calculated and visualized
using PyMOL. The surface of the repeat 1 domain molecule is color coded according to its electrostatic potential.
Blue and red, positive and negative regions, respectively (contoured at 6 kT /e).
and stability and in protein-protein recognition. Therefore this change in the electrostatic
potential of the wild-type repeat 1 domain and repeat 1-E2798K could affect the proper
folding and function of the protein.
8.2.2. Disulfide cross-linking within and between plectin repeats, and
between plectin and vimentin
Intramolecular disulfide bridges within the repeat 5 domain
To identify cysteine residues within the repeat 5 domain with reactive thiol groups that could
engage in disulfide bridge formation, the repeat 5 domain and the cysteine mutants were
tested for changes in their electrophoretic mobility due to disulfide-linked dimer or higher
oligomer formation. For this purpose, purified recombinant proteins were oxidatively
crosslinked by exposure to air at 4°C to promote disulfide bond formation, subsequently
treated with iodoacetamide to block free cysteine residues, and then subjected to SDS-PAGE
in the presence or absence of the reducing agent DTT. In the presence of DTT, the wild-type
version of the repeat domain 5 fragment and all mutant proteins occurred in the monomeric
form characteristic of the R5 wt fragment, migrating with an apparent molecular mass of 41
kDa (Fig. 16A, lane 10). In contrast, in the absence of DTT, several proteins bands
corresponding to monomeric, dimeric, and higher order oligomeric forms were observed
(Fig. 16A, lanes 1-9). The R5 wt fragment occurred as reduced (~41 kDa) and oxidized
monomers (~38 kDa), and was able to form dimers, trimers, tetramers, and other oligomers
(Fig. 16A, lane 1). Faster migration of the oxidized form compared to the reduced form of
the monomer is typical for intramolecular disulfide bonding, resulting in a more tightly
folded structure (Rogers et al., 1996; Locker and Griffiths, 1999). R5-C2S,C3S gave a cross-
linking pattern similar to that of R5 wt (Fig. 16A, lane 8). Since the only cysteines available
in the R5-C2S,C3S mutant are Cys1 and Cys4, I concluded that the oxidized forms of the
monomer were presumably formed by disulfide bond formation between these two residues.
Mutants R5-C1S and R5-C1S,C2S,C3S displayed two prominent bands corresponding to the
reduced form of the monomer (~41 kDa) and dimers with an abnormal mobility of ~100
kDa (Fig. 16A, lanes 2 and 5). Probably these dimers were formed by disulfide pairing of
two Cys4 residues in two different repeat 5 domain molecules. Cys4 resides in the linker
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region between the repeat domains 5 and 6 at a relatively large distance from the core region
of the repeat 5 domain. Disulfide bond formation between two Cys4 residues may therefore
generate dimers with a larger hydrodynamic dimension, thus migrating slower (apparent
molecular mass of ~100 kDa instead of ~82 kDa) in SDS-PAGE due to their extended
conformation (Peitsch et al., 2001; Uversky, 2002). In contrast, cross-linked R5-C4S formed
a dimer migrating with the expected mobility of a ~82 kDa protein (Fig. 16A, lane 7). R5
Cys-free occurred only as the reduced form of the monomer (~41 kDa) (Fig. 16A, lane 6).
In addition to a protein band with an apparent molecular mass of ~100 kDa, mutant R5-
C1S, C3S yielded a band corresponding to a higher oligomer (Fig. 16A, lane 3). The rest of
the mutants, R5-C1S,C2S, and R5-C1S,C4S remained in the monomeric form after oxidation
(~41 kDa; Fig. 16A, lanes 4, and 9).
These results provided evidence for the formation of an intra-repeat domain disulfide
bridge between Cys1 and Cys4. When either Cys1 or Cys4 were not available, oxidative
conditions promoted inter-repeat crosslinking (i.e. between distinct repeat 5 domain
molecules) and yielded two different types of dimers depending on the cysteine residue
engaged in the disulfide bridge. Inter-repeat domain crosslinking via Cys1 delivered dimers
in the regular conformation, migrating with the expected apparent molecular mass of 82 kDa
(see lane 7), while inter-repeat domain crosslinking via Cys4 delivered dimers with an
extended conformation that migrated slower. Bridges between the other cysteines were
unlikely to have occurred, because of distance restrictions between the cysteine residues (the
5.691 Å distance between the SH groups of Cys2 and Cys3 is beyond the optimum of 2.4
Å for creating a disulfide bridge). This assumption is supported by the fact that in the crystal
structure of desmoplakin’s domain B obtained in the absence of reducing agents (Choi et al.,
2002), disulfide bonding between cysteine residues 2259, 2433 and 2442, which are
equivalent to Cys1, Cys2 and Cys3 was not observed. Since the available high resolution
structural data on desmoplakin do not include the region where Cys4 resides, from structural
homology no information could be obtained regarding the putative disulfide bridge formation
between Cys1 and Cys4.
Intermolecular disulfide bridges between repeat domains 4 and 5
It has been speculated earlier that plectin’s repeat domains may bind to each other not only
due to hydrophobic and electrostatic interactions, but also due to disulfide bond formation
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between the repeats (Janda et al., 2001). To test this hypothesis I first examined whether the
single cysteine residue present in R4 was able to form a disulfide bond between two R4
molecules. When R4 oxidatively crosslinked under nonreducing conditions was analyzed,
two bands were found, one corresponding to the monomer, the other to the dimer, both with
the expected mobilities (Fig. 16B, lane 1), while a single monomeric band was observed
under reducing conditions. Next, I tested whether repeat domains 4 and 5 could be linked
via a disulfide bridge. Heterodimer formation was examined by incubating fragments R4
with R5 wt under reducing conditions for 1.5 h in the presence of 6 M urea, followed by
dialysis (to remove urea) and SDS-PAGE, both without reducing agents. Due to the size
difference of repeat domains 4 and 5 (~30 and ~41 kDa, respectively), a band of a size
between that of the homodimers (~61 and ~82 kDa, respectively) would be indicative of
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Figure 16.Disulfide cross-linking within and between plectin repeat 5 and 4 domains. (A) Analysis of cross-linked
products formed by wild-type and mutant versions of repeat 5 domain. Proteins oxidized by air were subjected to
SDS-10% PAGE under nonreducing (lanes 1-9) or reducing (lane 10) conditions. For reducing conditions, 0.2 M
DTT was added to 2x sample buffer to achieve a final concentration of 0.1 M. r, reduced. (B) Cross-linking of R4
with wild-type and cysteine-free repeat 5 domain. Lanes 1-3, cross-linked products of indicated single repeat do-
mains. Conditions similar to A except that 6M urea was added to the sample buffer. Lanes 4 and 5, cross-linked prod-
ucts of two repeat domains. R4 was mixed with either R5 wt, or R5 Cys-free, and air-oxidized. Samples were
resolved by SDS-10% PAGE under nonreducing conditions. Molecular masses of monomers and dimers of R4 are
~30 and ~60 kDa; of repeat 5 domain ~38, ~41 and ~82 kDa. Arrow indicates the heterodimer band (~66 kDa)
formed between R4 and R5 wt. Lanes M, molecular mass markers.
heterodimer formation. Such a band was indeed observed (Fig. 16B, lane 4). This band was
absent when R4 was incubated with the R5 Cys-free mutant (Fig. 16B, lane 5). Thus the
single cysteine in R4 as well as cysteines in repeat 5 domain, formed disulfide bonds not
only between their own molecular entities (R4-R4 and R5-R5 homodimers), but also between
each other (R4-R5 heterodimers).
Disulfide cross-linking between plectin’s repeat 5 domain and vimentin
As plectin’s repeat 5 domain could form intra- and inter-molecular disulfide bridges, the
question arose whether inter-molecular disulfide cross-linking between plectin’s repeat 5
domain and the unique cysteine of vimentin was possible. The assumption was that this type
of cross-linking could stabilize the association of vimentin with plectin.
To assess this hypothesis, polymerized vimentin was incubated with the R5 wt
fragment of plectin, or the R5 Cys-free fragment and then oxidized using the NO donor
reagent SNAP. Samples were analyzed by immunoblotting using antibodies that recognized
plectin’s repeat 5 domain or vimentin. Plectin R5 wt and R5 Cys-free alone detected by anti-
His-tag antibodies showed patterns corresponding with the ones observed by SDS-PAGE.
Anti-vimentin antibodies revealed two bands typical for vimentin, one corresponding to the
monomer, the other to the dimer. When it was tested whether plectin’s repeat 5 domain and
vimentin could be cross-linked via a disulfide bridge, anti-His-tag as well as anti-vimentin
antibodies revealed some additional bands (Fig. 17A, lane 4; and B, lane 4). The observation
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Figure 17.Disulfide cross-
linking between plectin's
repeat 5 domain and vi-
mentin. Polymerized vi-
mentin was incubated with
His-tagged plectin frag-
ments R5 wt, or R5 Cys-
free, and oxidized by
SNAP. Samples were then
subjected to SDS-10%
PAGE under nonreducing
conditions, and im-
munoblotted using anti-
His-tag (A), or anti-vimentin (B) antibodies. Lanes 1-3, vimentin, plectin R5 wt, and R5 Cys-free alone, respec-
tively. Lanes 4 and 5, cross-linked products of vimentin and repeat domain 5, respectively. Asterisks indicate plectin-
vimentin heterodimers identified by superposition of immunoblots.
of additional bands immunoreactive with both antibodies to plectin and vimentin would
indicate heterodimeric disulfide bond formation between plectin and vimentin. Such a band
was indeed observed (Fig. 17A, lane 4; and B, lane 4, asterisk). This band was absent when
vimentin was incubated with the cysteine-free mutant R5 Cys-free (Fig. 17A, lane 5; and B,
lane 5). Thus the single cysteine in vimentin as well as the cysteines in repeat domain 5
formed disulfide bonds between each other, which may lead to the stabilization of the
plectin-vimentin interaction.
8.2.3. Effects of plectin’s cysteine residues, of repeat domains neighboring
the IF-binding site, and of the tail region on plectin-vimentin affinity
Increased vimentin-binding affinity of plectin’s repeat domain 5 in its reduced form
Plectin’s major vimentin-binding site is located in the linker region connecting the repeat
domains 5 and 6. Since this region harbors also Cys4 of plectin’s repeat 5 domain (see Figure
14C), it was of special interest to examine whether this cysteine plays any role in the
interaction of the repeat 5 domain with vimentin. Therefore I measured the vimentin-binding
affinities of the fragment R5 wt and its cysteine-free variant R5 Cys-free, using a quantitative
non-radioactive binding assay based on Eu3+-labeled proteins (Soini and Kojola, 1983;
Nikolic et al., 1996). The two plectin fragments to be assessed, were coated under reducing
or nonreducing conditions onto 96-well microtiter plates and overlaid with increasing
concentrations of Eu3+-labeled vimentin. The amount of vimentin bound to microtiter plate-
immobilized plectin’s repeat 5 domain was determined by measuring released Eu3+ by
time-resolved fluorometry, using microtiter plate-bound BSA as control for non-specific
binding. The obtained dissociation constants showed that R5 wt bound to vimentin with 2-
times higher affinity under reducing (Kd=0.155 µM) compared to nonreducing conditions
(Kd=0.312 µM), while an even higher binding affinity (Kd=0.096 µM) was observed for the
mutant protein (Fig. 18). These differences in binding affinities probably reflected distinct
conformations of the reduced and the nonreduced forms of fragment R5 wt, on the one hand,
and of this fragment and its cysteine-free mutant, on the other.
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Effects of plectin’s repeat domains neighboring the IF-binding site and of the tail region
on plectin-vimentin interaction
The neighboring repeats 4 and 6 of plectin’s repeat 5 domain, contain one and three
cysteines, respectively; and their presence may affect the binding affinity to vimentin.
Therefore purified fragments R5-6, R5-6tail, and R4-5 were immobilized (under non-
reducing conditions) and overlaid with increasing amounts of Eu3+-labeled vimentin (Fig.
19). Scatchard transformation of the binding data showed that fragment R5-6 (Kd=0.174
µM) (Fig. 19A) bound to vimentin with an affinity that was very similar to that of fragment
R5 wt under reducing conditions (Kd=0.155 µM). However, the presence of the terminal tail
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Figure 18. Concentration-dependent binding of Eu3+-labeled vimentin to immobilized wild-type and cysteine-free
repeat domain 5. Fragments R5 wt in the absence (A), or presence of 1 mM DTT (B), and R5 Cys-free (without
DTT) (C) were coated onto microtiter plates at concentrations of 100 nM, and overlaid with Eu3+-labeled
recombinant vimentin at concentrations of 0.05-2 µM. Eu3+-labeled vimentin bound to the different versions of the
repeat 5 domain was measured. Scatchard plots of the binding data are shown.
region partially decreased the affinity (Kd=1.397 µM) (Fig. 19B). Interestingly, fragment
R4-5 (Kd=0.179 µM) displayed a vimentin-binding affinity that was very similar to that of
fragment R5-6 (Fig. 19C). The binding affinities of fragments R5-6 and R5-6tail resembled
the affinity of the R5 wild-type domain under reducing conditions (Kd=0.174 µM, 0.179
µM, and 0.155 µM, respectively).
These results suggested that the neighboring repeats of repeat 5 have a positive effect
on its binding to vimentin, reaching the affinity levels measured for the wild-type version of
R5 in its reduced form. These finding led me to suggest, that plectin’s intra-repeat disulfide
bridges decreased the affinity to vimentin, while the inter-repeat disulfide bridges increased
it.
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Figure 19. Concentration-dependent binding of Eu3+-labeled vimentin to immobilized fragments R5-6, R5-6tail,
and R4-5. R5-6 (A), R5-6tail (B), and R4-5 (C) were coated onto microtiter plates at concentrations of 100 nM, and
overlaid with Eu3+-labeled recombinant vimentin at concentrations of 0.05-2 µM. Eu3+-labeled vimentin bound to
the different versions of the repeat 5 domain was measured. Scatchard plots of the binding data are shown.
8.2.4. Plectin is a target for nitrosylation in vitro and in vivo
In vitro nitrosylation of cysteine 4 in plectin’s repeat 5 domain
S-nitrosylation is a reversible posttranslational modification with a potential role in the
regulation of protein function in response to oxidative stress. Mechanistically, S-nitrosylation
is the reversible covalent binding of NO to an SH-group of a reactive cysteine, and it is
precisely targeted to residues in hydrophilic protein domains that contain consensus acid-
basic motifs consisting of a core of three residues, K/R/H/D/E–C–D/E (Stamler et al., 1997).
As the forth cysteine (Cys4) in repeat domain 5 meets these criteria, an in vitro S-
nitrosylation assay was carried out, using fragments R5 wt and R5-C4S as the protein
substrates, SNAP as the NO donor, and the biotin switch method for detection of S-
nitrosylated cysteines. In this assay, after blocking non-nitrosylated free thiol groups by
methylation, S-nitrosylated cysteines are selectively identified by the cleavage of S-NO by
ascorbate followed by biotinylation of the free thiols, pull down of biotinylated proteins
with streptavidin beads, and immunoblotting of eluates. As shown in Fig. 20A, extensive
nitrosylation of fragment R5 wt preincubated with SNAP was observed, while hardly any
signal was detected with R5-C4S.
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Figure 20. Nitrosylation of fragment R5 Cys4 in vitro and of plectin in cultured endothelial cells in vivo. (A) Ni-
trosylation in vitro. Purified samples (80 µg) of R5 wt and mutant R5-C4S were incubated with 100 µM SNAP, and
S-nitrosylated proteins detected by the biotin switch method. Biotinylated proteins were purified on streptavidin
beads, eluted with β-ME, immunoblotted (SDS-10% PAGE), and probed with antibodies to HIS-tag. (B) NO donor-
mediated S-nitrosylation of plectin in cultured mouse renal endothelial cells. Cells preincubated with 100 µM SNAP
were lysed in blocking buffer (see text) and processed as described in A. Eluted proteins were subjected to im-
munoblotting (SDS-5% PAGE) and probed with antibodies to plectin (upper panels). Control, ascorbate added
prior to blocking free thiols. Lower panel, membranes were stripped and reblotted with anti e-NOS antibodies. (C)
S-nitrosylation of plectin in cultured mouse renal endothelial cells after stimulation of endogenous eNOS. Cells,
kept untreated or incubated with 100 nM PMA for 20 h, were lysed and processed as described in B. In A, 0.8% of
the starting material and 25% of the eluates were loaded onto the gels; in B and C, 3.3% of the cell lysates and 50%
of the eluates.
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Nitrosylation of plectin in endothelial cell cultures
Nitric oxide plays a key regulatory role in endothelial cell function (Hess et al., 2005). To
investigate whether plectin S-nitrosylation occurs in vivo, I incubated immortalized mouse
renal endothelial cells in culture with SNAP and assayed plectin S-nitrosylation by the biotin-
switch assay. As shown in Fig. 20B, a strong signal corresponding to full length plectin
could be detected in the streptavidin-bead eluate, indicating S-nitrosylation of endogenous
endothelial cell plectin. When ascorbate (1 mM) was added to the samples prior to blocking
free (non-nitrosylated) thiol groups, no plectin signal was detectable in the eluate (Fig. 20B,
control), validating the assay. As an additional control, the membrane was stripped and
overlaid with antibodies to eNOS, which itself is a target of nitrosylation (Ravi et al., 2004),
revealing, as expected, the presence of the enzyme in both, the starting cell lysate and the
eluate recovered from the streptavidin beads (Fig. 20B, eNOS).
Next, I examined whether plectin can be S-nitrosylated by an endogenous mechanism
of NO generation. For this purpose I treated cultured endothelial cells with PMA and
subjected the cell lysates to the biotin-switch assay. PMA, an agonist of PKC, has been
shown to increase expression and enzymatic activity of eNOS in endothelial cells (Li et al.,
1998; Shen et al., 2001). As shown in Figure 20C, plectin was indeed S-nitrosylated by
endogenously generated NO, whereas at basal NO levels (no PMA treatment), neither plectin
nor eNOS were nitrosylated.
8.2.5. Effect of NO donor-mediated nitrosylation on the cytoskeleton of
endothelial cell
Cytoarchitecture of vimentin networks
To assess whether S-nitrosylation induced by NO donors had any effects on IF network
cytoarchitecture, subconfluent cultures of immortalized mouse renal endothelial cells were
subjected to immunofluorescence microscopy after exposure to the NO donor SNAP for 2, 4,
or 6 h. Visualizing vimentin, the major constituent protein of endothelial IF networks, well
spread cellular networks were observed at all time points, with no detectable differences
becoming apparent between untreated and 6 hour-treated cells (compare Fig. 21, A-D). In
contrast, when a similar experiment was carried out with immortalized plectin-deficient
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Figure 21. Immunofluorescence microscopy of wild-type and plectin-deficient endothelial cells after nitrosyla-
tion with SNAP. (A-J) Cells were untreated, or treated with SNAP for 2h, 4h, or 6h, prior to immunostaining, using
antibodies to vimentin, or tubulin as indicated. Bars, 30 µm (A-E, I), and 20 µm (F-H, J). (K-N) Bar diagrams
showing statistical evaluation of cells with normal, partially collapsed, and completely collapsed vimentin net-
works. Data shown represent mean values (±SEM) of three independent experiments (>100 cells per experiment
were counted from randomly chosen optical fields).
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endothelial cells, a progressive collapse of vimentin filament networks into perinuclear
bundles was observed. A partial collapse was visible in some cells already at the 2 hour time
point (Fig. 21G), while after 6 hours hardly any of the cells contained intact filaments (Fig.
21 I). In contrast, microtubules appeared unaffected by the SNAP treatment (Fig. 21, E and
J). A statistical evaluation of over 100 wild-type and mutant cells, each, per time point (Fig.
21, K-N), revealed that while in wild-type cells the proportions of cells with intact (normal),
partially collapsed, and fully collapsed IF networks were ~97:3:0 in untreated cells, compared
to ~95:4:1 in 6 hours SNAP-exposed cells, in plectin-deficient cells the corresponding values
were ~93:6:1 and ~1:8:91, respectively (Fig. 22, K-N). This strongly suggested an
antagonistic role of plectin in S-nitrosylation-mediated vimentin filament collapse.
Effect of NO donor-mediated nitrosylation on microfilaments and focal adhesion
contacts
A major biological significance of plectin’s interaction with actin was revealed in studies
on primary fibroblasts and astroglial cell cultures obtained from plectin-/- mice. Andrä et al.
(1998) found that the actin cytoskeleton, including focal adhesion contacts (FACs), was more
extensively developed in plectin-deficient compared to wild-type cells. To investigate
whether nitrosylation had any effects on microfilament network structure, endothelial cells
deficient in plectin and corresponding cells from wild-type littermates were incubated with
the NO donor SNAP and then subjected to immunofluorescence microscopy using antibodies
to actin and to vinculin. As previously shown, untreated plectin-deficient fibroblasts showed
a significant increase in the number of actin stress fibers and of vinculin-positive FACs
compared to wild-type cells (compare Figs. 22 A-C with G-I). Upon treatment with the NO
donor, several interesting phenomena were observed. First of all, in wild-type cells, actin
stress fibers became restricted to regions in the cell centers (Fig. 22D), paralleled by the
relocalization of vinculin-positive FACs (Fig. 22E) to the ends of the stress fibers in the
same regions (Fig. 22, E and F). Interestingly, plectin-deficient endothelial cells did not
show this retraction effect of microfilaments to the cell center upon SNAP treatment. Instead,
I observed an increased number of stress fibers extending all the way to the periphery of
cells, accompanied by an accumulation of FACs at the cell edges (Figs. 22, J-L). While NO
donor-mediated nitrosylation caused the collapse of vimentin networks in the absence of
plectin, the actin filament network in plectin-/- cells did not show any significant changes.
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Figure 22. Immunofluorescence microscopy of wild-type (+/+) and plectin-deficient (-/-) endothelial cells before
(untreated) and after nitrosylation using SNAP. Cells were immunostained using antibodies to actin or vinculin as
indicated. Bar, 20 µm.
8.2.6. Distribution, expression, and activity of eNOS in plectin-deficient
endothelial cells
NO release from plectin-deficient compared to wild-type endothelial cells
After having shown that NO differentially affects cytoskeletal filament systems in plectin-
deficient and wild-type cells, it was of interest to assess whether plectin was involved in
NO-based signaling pathways. To address this question, I tested the influence of plectin
deficiency on the NO levels released from endothelial cells. In cooperation with V. Dirsch
& C. Schmitt (Department of Pharmacognosy, University of Vienna) NO production was
quantified using the fluorescent probe DAF-2 in cell culture supernatants of endothelial cells
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Figure 23. NO release from endothelial cells. Plectin+/+ or plectin-/- endothelial cells were untreated or treated with
either the protein kinase A activator PMA, or the irreversible eNOS inhibitor L-NAA. NO was quantified in cell
culture supernatants using the fluorescent probe DAF-2. Fluorescence units were normalized to the number of cells.
Data shown represent mean values (±SEM) of three independent experiments, each performed at least in tripli-
cates.
that had previously been stimulated by the eNOS activator PMA (Leikert et al., 2001; Rathel
et al., 2003). As a result of eNOS stimulation, NO released from endothelial cells increased
to levels of 160% in comparison to unstimulated cells (100%) (Fig. 23). Interestingly, when
unstimulated, plectin-deficient endothelial cells showed very low NO production, and even
when eNOS was stimulated, NO production stayed unchanged. When a similar experiment
was carried out with cells treated with the eNOS inhibitor L-NAA, NO production in wild-
type cells significantly decreased, reaching a level comparable to that detected in the
untreated plectin-deficient cells; NO production in plectin-/- cells remained unchanged (Fig.
23). These results suggested that plectin was important for NO production by eNOS, as in
its absence the production of NO was considerably lower, if not brought to a stop.
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Figure 24. Expression and
activation (phosphorylation)
levels of eNOS. (A) En-
dothelial cells were either
left untreated or treated with
eNOS activator. Lysates
from these cells were sub-
jected to electrophoresis and
immunoblotting was per-
formed using antibodies to
total eNOS, eNOS phospho-
epitopes threonine 495 and
serine 1177, Akt/protein ki-
nase B, and its phosphoepi-
tope serine 1177. Actin was
used as a loading control.
(B) Signal intensities of the
bands, which were densito-
metrically determined in
three independent experi-
ments, were normalized to
actin (mean ± SEM). au, ar-
bitrary units.
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Expression and activation (phosphorylation) levels of eNOS
In order to determine whether the decreased NO production in plectin-deficient endothelial
cells was due to decreased eNOS protein levels or activation, cell lysates from plectin+/+ and
plectin-/- endothelial cells were analyzed by immunoblotting. Cell lysates prepared from
endothelial cells treated with eNOS activator, were analyzed using antibodies recognizing
either all forms of eNOS (activated and inactivated) or only the phosphoepitopes
characteristic of activated eNOS, such as phosphorylated threonine 495 and serine 1177
(Fleming and Busse, 2003; see details in Introduction). As shown in Fig. 24 (A and B, total
eNOS) the data obtained corresponded to the measurements of NO production. In particular,
in wild-type endothelial cells the total eNOS protein level was partially increased upon
activation by PMA (Fig. 24, A and B; total eNOS; +/+). In contrast, in both untreated and
treated plectin-deficient cells hardly any eNOS signal was detected (Fig. 24, A and B; total
eNOS). Antibodies to the phosphoepitopes threonine 495 and serine 1177 showed patterns
similar to that of total eNOS (Fig. 24, A and B; eNOS Thr495, eNOS Ser1177).
Protein kinase B/Akt is one of the kinases shown to phosphorylate and activate serine
1177 of eNOS. To find out whether the protein level or activation of this upstream activator
kinase was similarly influenced by plectin deficiency, immunoblottings were performed using
antibodies to total Akt kinase and alternatively to its phosphoepitope serine 473, that is
responsible for its activation. Unlike eNOS, the protein level of total Akt kinase as well as
the phosphoepitope serine 473 signal were very similar in wild-type and plectin-deficient
cells, independent of whether they were PMA-treated or not (Fig. 24, A and B; total Akt, Akt
Ser473).
Thus, the loss of NO production seemed to be a result of very low protein levels of
eNOS, which would speak for an involvement of plectin in the regulation of eNOS
expression and/or eNOS degradation. As these experiments were performed with
immortalized cell cultures, which may have changed properties compared to genuine (non-
immortalized) primary cells, in future studies, they should be confirmed using
non-immortalized primary cell cultures.
Distribution of eNOS in endothelial cells
The observed decreased NO production and protein levels of eNOS in the absence of plectin
prompted me to study the cellular localization of eNOS in endothelial cells. This was of
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Figure 25. Immunofluorescence microscopy of wild-type and plectin-deficient endothelial cells after activation of
eNOS. Cells were untreated, or treated with PMA, prior to immunostaining for eNOS, and vimentin. Bar, 20 µm.
importance considering that membrane-bound eNOS associated with caveolin-1 in caveolae
was found to be silenced and dependent on the activating mechanisms that disrupt its
interaction with caveolin-1. Translocation of eNOS from caveolae to intracellular sites was
found to result in the attenuation of NO production (Wu, 2002). Monitoring eNOS by
immunofluorescence microscopy in wild-type endothelial cells upon eNOS induction, I
found the enzyme to be diffusely distributed over the whole cytoplasm, which would
correspond to the active form of eNOS (Fig. 25A). I did not observe any differences in the
distribution of eNOS between untreated and PMA-treated cells (compare Fig. 25, A and D).
In plectin knockout cells the eNOS signal was mainly observed at the periphery of cells,
which would correspond to the inactive form of the enzyme (Fig. 25, G and J). These
findings together with the results from expression/activation levels of eNOS, suggest a
regulatory effect of plectin on eNOS activity.
8.3. PHOSPHORYLATION OF PLECTIN AND ITS EFFECT ON THE
FORMATION OF VIMENTIN NETWORKS AND IF INTERMEDIATES
8.3.1. Plectin and vimentin form globular complexes upon phosphorylation
by Cdk1 in vitro
As a cytoplasmic crosslinking element plectin could play an important role during mitosis
when the cytoskeleton, including IF networks, is dramatically reorganized. It has previously
been reported, that phosphorylation of plectin by serine/threonine kinases, including mitotic
Cdk1, affects its binding affinity to vimentin (Foisner et al., 1991; Foisner et al., 1996;
Malecz et al., 1996), suggesting that mitosis-specific phosphorylation regulates plectin’s
cross-linking activities and association with IFs. Both, plectin and vimentin have been shown
to possess unique target sites for Cdk1 (Chou et al., 1990; Chou et al., 1991; Malecz et al.,
1996), with plectin’s phosphorylation site residing in the repeat 6 domain, not far from the
IF-binding site. Phosphorylation of vimentin by mitotic Cdk1 has been shown to correlate
with the disassembly of vimentin IF networks (Chou et al., 1990; Tsujimura et al., 1994).
To assess the effects of protein phosphorylation on the formation and binding affinity
of plectin-vimentin protein complexes in vitro, recombinant versions of mouse vimentin and
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Figure 26. Formation of globular complexes from vimentin and a C-terminal plectin fragment upon Cdk1 phos-
phorylation in vitro. Electron microscopy of uranyl acetate-stained oligomeric structures formed from recombi-
nant vimentin alone (A and D), plectin domain R5-6 alone (B and E), or equimolar mixtures of both (C and F).
Specimens shown in A-C were unphosphorylated, those in D-F were phosphorylated by Cdk1 prior to incubation
under assembly conditions and processing for electron microscopy (for details see text). Bar = 50 nm.
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of plectin domain R5-6, a C-terminal fragment of plectin containing its major IF-binding
site flanked by two of its six repeat domains, were incubated with Cdk1 in various
combinations under filament assembly conditions. Filaments assembled from vimentin alone,
without prior incubation with Cdk1, were observed by negative staining electron microscopy
predominantly in the form of loose filamentous networks (Fig. 26A). When preassembled
filaments were incubated with roughly equimolar amounts of plectin R5-6 the networks
formed were non-uniformly decorated with globular structures, presumably consisting of
clustered plectin R5-6 molecules or complexes of R5-6 and vimentin (Fig. 26C). Plectin R5-
6 incubated alone (without vimentin) under similar conditions formed aggregates of variable
sizes and shapes (Fig. 26B), which were seen also in samples of R5-6-vimentin mixtures,
without however showing association with filaments (Fig. 26C).
Upon phosphorylation of in vitro assembled vimentin filaments by Cdk1 (recombi-
nant Cdk1/cyclinB complex; Chou et al., 1991), disassembly of filaments was observed,
with the concurrent appearance of short fibrils and small aggregates (Fig. 26D). The
appearance of plectin R5-6 was unaltered after Cdk1 phosphorylation (Fig. 26E). However,
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when Cdk1-phosphorylated vimentin was subjected to assembly conditions in the presence
of phosphorylated plectin R5-6, globule-like structures with diameters of ~150 nm were
visualized (Fig. 26F).
To gain more insight into the mechanism of globular particle formation, I examined
whether Cdk1 or PKC phosphorylation of plectin and vimentin affected their binding
affinities. To assess binding, unphosphorylated or in vitro phosphorylated samples of plectin
fragments R5-6 or R5-6tail were coated onto microtiter plates, and overlaid with Eu3+-labeled
(either unphosphorylated or phosphorylated) vimentin. Vimentin bound was then quanti-
tatively determined after release of complexed Eu3+ and detection by time-resolved
fluorometry (Soini and Kojola, 1983; Nikolic et al., 1996). As shown in Fig. 27A, Cdk1-
phosphorylation of both proteins, plectin domain R5-6/R5-6tail and vimentin, led to an
affinity comparable to that of the unphosphorylated forms (Fig. 27A, P*+V* versus P+V).
Cdk1-phosphorylated plectin R5-6 showed lower (60%), albeit still significant, binding to
vimentin compared to the unphosphorylated form (Fig. 27A, P*+V). In the reverse case,
where vimentin but not plectin was phosphorylated, binding was considerably increased
(Fig. 27A, P+V*). This elevation might be explained by an increased number of binding
sites being accessible on phosphorylated (non-filamentous) vimentin which is known to exist
as tetrameric molecules. Very similar results were obtained when I used plectin fragment
R5-6tail. A general reduction in binding (~25% compared to the tail-less R5-6 domain)
observed in this case pointed towards an influence of the tail domain on binding (Fig. 27A).
The relatively small differences in binding affinities of Cdk1-phosphorylated, compared to
non-phosphorylated forms of both proteins (see Fig. 27A) indicated that plectin and vimentin
can bind to each other regardless of their Cdk1-phosphorylation status. This explains that,
albeit Cdk1 phosphorylation causes the release of plectin from filamentous vimentin at the
onset of mitosis in certain cell types, such as CHO cells (Foisner et al., 1996), a fraction of
both proteins could also stay associated throughout mitosis. The association of both proteins
during mitosis has also been reported by BHK-21 cells (Skalli et al., 1992). As the behavior
of IF networks during mitosis considerably varies between cell types (Chou et al., 2007), so
will probably also the fractions of both proteins forming a complex during mitosis.
Phosphorylation of plectin R5-6 and R5-6tail using protein kinase CβII (PKC) instead
of Cdk1 decreased its affinity to vimentin to a similar level (~60%) as Cdk1 (Fig. 27B,
P*+V, +DAG/PS). When a similar experiment was performed in the absence of DAG/PS
8.3.2. Plectin deficiency affects vimentin network dynamics during cell
division and leads to multipolar spindles
In interphase cells, cytoplasmic IF proteins typically form a network that extends from the
nuclear surface towards the cell periphery, but as cells enter into mitosis, IFs are dramatically
reorganized. Vimentin remains in partially filamentous form in some cells, or disassembles
into non-filamentous granules in other cells upon phosphorylation by mitotic Cdk1 (Aubin
et al., 1980; Franke et al., 1982; Rosevear et al., 1990; Chou et al., 2007).
In view of globule-like structure formation of mitotic Cdk1-phosphorylated vimentin
in the presence of phosphorylated plectin R5-6, it was of interest to assess whether similar
structures were present in dividing cells and whether plectin was associated with such
structures. To address these questions, plectin+/+ and plectin-/- fibroblast cell cultures were
synchronized by double thymidine block followed by nocodazole-induced mitotic arrest.
Detached premitotic cells were plated onto polylysine-coated coverslips and vimentin
remodeling during various mitotic stages and new network formation during cytokinesis
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(diacylglycerol/phosphatidylserine) the activity decreased to 40% (Fig. 27B, P*+V, -
DAG/PS). Plectin fragment R5-6tail showed similar tendencies although binding affinities
in general were lower then that of fragment R5-6.
Figure 27. Binding of recombinant plectin domain R5-6 or R5-6tail to vimentin with and without Cdk1 (A) or
PKCβII (B) phosphorylation. Phosphorylated or unphosphorylated samples of R5-6/R5-6tail were coated onto mi-
crotiter plates at concentrations of 100 nM, and overlaid with Eu3+-labeled, phosphorylated/unphosphorylated re-
combinant vimentin at concentrations of 500 nM. P, plectin; V, vimentin; P*, V*, phosphorylated plectin and
vimentin, respectively; DAG/PS, diacylglycerol/ phosphatidylserine. Data represent the mean ± SEM of three in-
dependent experiments. * and **, P < 0.05 and P < 0.01, respectively.
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Figure 28. Immunofluorescence microscopy of wild-type and plectin-deficient fibroblasts during mitosis. A, Cells
were synchronized by double thymidine block and fixed during prophase (a, e), metaphase (b, f), anaphase (c, g),
and telophase/cytokinesis phase (d, h). For immunostaining, antibodies to vimentin, tubulin, and plectin were used,
as indicated. DNA was visualized with Hoechst dye. Boxed areas in d and h are shown as magnified images in d’,
d”, and h’. Bar (g) = 20 µm (representative for rows prophase, metaphase and anaphase); bar (h) = 20 µm (repre-
sentative for row postmitotic); bar (h’) = 5µm (representative for bottom row). B, Areas of daughter cell pairs. Black
and grey columns represent larger and smaller cells, respectively. Values are based on the analysis of 20 pairs of
daughter cells. C, Statistical evaluation of the length of mitosis. For each time point, the percentage of cells that had
reached cytokinesis after nocodazol release and were connected by an intercellular bridge was calculated. D, Inci-
dence of cells with multipolar spindles in immortalized or primary cells. Percentage was calculated by scoring 200
mitotic cells. Error bars represent SEM based on three independent experiments. †, P < 0.001.
were analyzed by immunofluorescence microscopy. In prophase, characterized by the
appearance of two centrioles, vimentin networks in wild-type cells were found to have
disassembled only partially, as filamentous structures were clearly visible, particularly in
peripheral regions of the cell (Fig. 28A, a). These structures were maintained in metaphase,
where they formed a cage-like network around the bipolar spindle (Fig. 28A, b). Upon
chromosome separation, starting in anaphase and extending into telophase, these persisting
filamentous vimentin structures became partitioned between the two newly forming cells
(Fig. 28A, c). The majority of wild-type cells undergoing cytokinesis showed an uneven
distribution of the vimentin network to the daughter cells (Fig. 28A, d), as confirmed by
taking Z-stacks of the vimentin staining. Not unexpected, postmitotic cells displayed less
vimentin structures in the smaller one of two daughter cells (Fig. 29, +/+). In newly
spreading postmitotic cells, vimentin filament intermediates in the form of granules and
squiggles were clearly visualized in peripheral region of wild-type cells (Fig. 28A, d’), and
these structures were associated with plectin (Fig. 28A, d”). The shape and size of these
vimentin granules in the postmitotic fibroblasts resembled that of globule-like structures
formed when Cdk1-phosphorylated vimentin was assembled in the presence of phospho-
rylated plectin R5-6 (Fig. 26F), supporting the notion that the interaction of plectin with
vimentin was important for their formation in vivo.
In mitotic plectin-deficient fibroblasts, I noticed several differences. During prophase
and all the following stages of mitosis, vimentin-positive structures appeared less filamentous
than those of wild-type cells (Fig. 28A, e-g; compare with a-c), suggesting that mitotic
vimentin structures became more soluble in the absence of plectin. In addition, the majority
of plectin-deficient prophase cells appeared to be larger than their wild-type counterparts
and they showed prominent tubulin-specific staining associated with subplasma membrane
structures partially overlapping with vimentin-positive structures (Fig. 28A, e). The hallmark
feature of plectin-/- cells, however, was the display of multiple centrioles during prophase and
of multipolar spindles in meta- and anaphase, as revealed using anti-α-tubulin antibodies
(Fig. 28A, f and g). Interestingly, there was also a much more even distribution of vimentin
structures to separating daughter cells (Figs. 28A, h and 29, -/-), and finally, unlike wild-type
cells, vimentin network assembly in postmitotic plectin-deficient cells occurred without the
formation of granules and squiggles as intermediates (Fig. 28A, h and h’).
A statistical analysis of the areas occupied by postmitotic daughter cells in wild-type
80
81
+/+ -/-
Tu
bu
lin
/ V
im
en
tin
/ D
N
A
V i
m
en
tin
/ D
N
A
0.00 mm 0.00 mm
0. 0 m6 m
0. 0 m9 m
1 2. 0 mm
1 5. 0 mm
merge merge
0.4 m5 m
0. m90 m
1 35. mm
1 80. mm
Figure 29. Immunofluorescence microscopy (Z-stacks)
of postmitotic cells showing differences in the distribu-
tion of vimentin stuctures in wild-type and plectin-defi-
cient fibroblasts. Z-stacks were taken at intervals indicated
in panels. Combined Z-stack images of vimentin, tubulin,
and DNA are shown in top panels (merge); individual Z-
stack images show only vimentin and DNA signals. Note
unequal versus equal distribution of vimentin signals in
plectin+/+ and plectin-/- cells, respectively. Bar = 20 µm.
and plectin-/- cultures clearly showed that the partitioning of vimentin structures between
daughter cells correlated with their size. As shown in Fig. 28B, wild-type daughter cells
showed an almost 3-fold difference in occupied areas (~388 versus ~1132 µm2), whereas
corresponding areas measured for plectin-/- cells varied insignificantly, ranging from 869–
1028 µm2. Next, I examined whether the differences in IF assembly/disassembly patterns
observed in wild-type and plectin-deficient fibroblasts correlated with differences in their
progression through mitosis. For this, I carried out a statistical analysis of synchronized cells
that had passed through mitosis and started to undergo cytokinesis. As shown in Fig. 28C,
already 55% of plectin-/- cells had reached this stage within 60 min after nocodazole release,
compared to only 3% of wild-type cells. Nearly all, namely 99%, of plectin-/- fibroblasts had
passed through mitosis within 120 min, whereas this applied to only 68% of wild-type cells;
plectin+/+ fibroblasts had not finished cell division before 180 min (Fig. 28C). I attributed this
difference to the fact that cells containing more loosely networked vimentin (due to the lack
of plectin crossbridges) more readily undergo the structural reorganization that takes place
during mitosis and cytokinesis. For a similar reason, vimentin is likely to get segregated
more evenly to the two daughter cells. The uneven distribution of IFs becomes evident upon
examination of pictures published as far back as 1980 (Aubin et al., 1980), although this
phenomenon has not been discussed much. In all, these data revealed an interesting
correlation between plectin-regulated IF dynamics and the duration and rate of mitosis.
The hallmark of plectin-deficient mitotic cells, centrosome amplification and
multipolar spindles, was observed in ~90% of synchronized cells, compared to only 10% of
similar wild-type cells (Fig. 28D). Inactivation of p53, which was used to obtain
immortalized cell cultures, is known to result in centrosome amplification due to deregulation
of the centrosome duplication cycle and failure to undergo cytokinesis (Fukasawa et al.,
1996; Meraldi and Nigg, 2002; Tarapore and Fukasawa, 2002; Shinmura et al., 2007). As
plectin+/+ and plectin-/- fibroblasts were both lacking functional p53, the absence of p53 is
unlikely to have accounted for the dramatic increase in multipolar spindle formation in
plectin-deficient cells (P < 0.001). Nevertheless, to confirm that it must have been the loss
of the plectin allele that greatly boosted multipolar spindle formation, I collected mitotic
cells from primary cell cultures derived from p53 wild-type mice (p53+/+) by mitotic shake-
off (isolation of cells in sufficient amounts for synchronization was not possible), plated
them and counted the cells carrying bipolar or multipolar spindles. The ratio of cells with
bipolar spindles to those with multipolar spindles was 12:1 (n = 200) in the case of plectin-
null cells compared to 49:1 (n = 200) for wild-type cells (plectin+/+ versus plectin-/-; P <
0.05; Fig. 28D). Together these data clearly suggested a role for plectin in centromere
duplication and/or spindle assembly.
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8.3.3. Plectin-dependent formation of vimentin filament intermediates
delays IF network assembly
IF networks assemble sequentially in several steps, from non-filamentous granules, short
fibrous squiggles, to long fibrils, as shown by in vivo studies (Prahlad et al., 1998; Chou and
Goldman, 2000). Although the binding of plectin to IFs, in particular to vimentin, has long
been established using different methodologies (for review see Rezniczek et al., 2004), the
issue of whether plectin-binding affects dynamic properties of IFs has not been addressed
yet. Plectin as a major organizing element of IF network cytoarchitecture, may well have a
function in IF network assembly and dynamics. Therefore the following questions were
addressed: Is plectin-vimentin binding involved in the formation of IF intermediates,
particularly of granules and squiggles, and if plectin influences the formation of IF
intermediates, is it part of such structures?
To assess whether plectin has any influence on IF assembly, trypsinized cultures of
immortalized plectin+/+ and plectin-/- mouse fibroblasts were replated, and polymeric vimentin
structures forming during cell spreading were monitored by immunofluorescence
microscopy. As described by Goldman and Follett (Goldman and Follett, 1970), in wild-
type cells IFs lost their extended network organization during trypsinization and collapsed
into juxtanuclear aggregates that persisted up to 30 min after replating (Fig. 30A, a).
Globular vimentin structures were observed in peripheral regions of such cells within 45
min after replating (Fig. 30A, b, b’, b“). 120 min after replating, short filamentous vimentin
structures resembling squiggles (Prahlad et al., 1998) became dominant over globular
structures in these regions (Fig. 30A, c, c’, c“). After 240 min, short squiggles were replaced
by longer filamentous structures, and finally after 360 min, granules, squiggles, or
filamentous structures with two free ends were hardly observed anymore (Fig. 30A, d). At
that stage, IFs formed a delicate fibrous network concentrated around the nucleus with only
a few filaments extending all the way to the cell periphery. As in postmitotic cells, all
vimentin filament intermediates in the form of granules and squiggles have found to be
associated with plectin (Fig. 30A, b“, c“). The microtubule network, showing a considerably
faster assembly rate throughout cell spreading, had already reached its fully extended state
at this time (Fig. 30A, e-h; note that single channel images of the same cells double-labeled
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Figure 30. Immunofluorescence microscopy of wild-type (+/+) and plectin-deficient (-/-) fibroblasts. A, Cells were
fixed at the times indicated (30, 45, 120, or 360 min) after trypsinization and replating, and immunostained using anti-
bodies to vimentin, tubulin, or plectin, as indicated. The boxed areas in b, c, and j (designated with corresponding
primed letters) are shown as magnified images in the bottom row (detail). Bar (p) = 20 µm (representative for column
360 min); bar (o) = 20 µm (representative for columns 30, 45, and 120 min); bar (j’) = 5 µm (representative for bottom
row). B, Circle diagrams showing statistical evaluation of granule and squiggle compositions. Counts were taken from
randomly chosen cells (n = 9), at time-points 45 min (granules and particles) and 120 min (squiggles); more than 100
granules or squiggles were counted per cell. Results represent average values from three independent experiments.
for vimentin and tubulin are shown in series a-d and e-h, respectively). Consistent with
reports showing transport of squiggles along microtubules (Prahlad et al., 1998; Yabe et al.,
1999a; Helfand et al., 2002), the majority of vimentin granules and squiggles forming during
cell spreading co-aligned with microtubules.
In plectin-deficient fibroblasts, the formation of vimentin-positive granules or
squiggles was not observed at any stage of cell spreading (Fig. 30A, i-l). However, a few
quite long (up to ~12 µm) filamentous structures with two free ends, presumably representing
fragmented filaments, could occasionally be visualized in some of the cells, albeit not before
the 120-min time point (Fig. 30A, k, asterisks). Interestingly, the formation of vimentin
networks proceeded noticeably faster in the absence of plectin. Fully-spread vimentin
networks had already formed within 120 min, compared to 360 min and more in wild-type
cells (compare Figs. 30A, k and d). Both phenotypes, absence of filament intermediates and
faster IF network formation, could be confirmed using primary cultures of plectin-/-
fibroblasts (Fig. 31). Thus, IF network formation in cells that were spreading after
85
+/
+
-/-
A
C D F
H I
B A' C'
120 min 360 min detail
A'
C'
Figure 31. Immunofluorescence microscopy of primary wild-type (+/+) and plectin-deficient (-/-) fibroblasts. Cells
were fixed at the times indicated (120 or 360 min) after trypsinization and replating, and immunostained using
antibodies to vimentin, as indicated. The boxed areas in A and C (designated with corresponding primed letters) are
shown as magnified images (detail). Bar = 20 µm.
trypsinization/replating in both wild-type and mutant cells followed patterns very similar to
those of postmitotic cells.
A detailed examination of double-immunostained plectin+/+ fibroblasts during the time
window when vimentin filament intermediates were formed (45-120 min), revealed that
vimentin and plectin could form three different populations of globular structures, consisting
of either both proteins, or each one alone. A statistical analysis showed that 45 min after
replating only 45% of vimentin-positive granules observed were also plectin-positive (Fig.
30B, 45 min). Interestingly, 120 min after replating, when vimentin intermediates had already
reached the stage of squiggles, most of them (74%) turned out to be plectin-positive (Fig.
30B, 120 min). A similar analysis of plectin-positive particles revealed that more than half
(57%) were vimentin-negative (Fig. 30B, 45 min) and this percentage increased to 70% at
the later stage (Fig. 30B, 120 min). These results suggested that while most of the vimentin
was associated with plectin as filaments formed, plenty of plectin remained in a vimentin-
unassociated state. Furthermore, the absence of vimentin intermediates in plectin-null
fibroblasts pointed to a requirement for plectin in promoting their assembly.
8.3.4. Plectin-containing vimentin squiggles exhibit directional movement
towards the cell periphery
Recent studies have revealed, that IFs are highly dynamic polymers, with three types of
intermediate structures - granules, squiggles, and longer filaments. Furthermore, the smaller
subunits were found to be motile, assembling into polymerized IFs in a stepwise process
(Chou and Goldman, 2000; Chou et al., 2007). As the monitoring of vimentin and plectin
during cell spreading showed, that plectin was associated with vimentin from the early stages
of assembly and that the formation of vimentin intermediates was plectin dependent, the
question arose whether plectin influences the transport and kinetics of vimentin intermediates
and/or the stepwise formation of stable IFs.
To monitor vimentin granule and squiggle formation during fibroblast cell spreading
in vivo, cells were transiently transfected with a cDNA expression vector encoding a GFP–
vimentin fusion protein. Twenty four hours after transfection, cells were trypsinized and
replated, and the behavior of the fusion protein was monitored by time-lapse microscopy of
86
87
-/
-
+
/+
0 :13 0
0 :59 0 10:10 10:30 10:50 11:10
0 :33 0 0 :53 0 0 :14 0 0 :34 0
A
B
D EC
-/
-
0 :50 0 0 :11 0 1 :51 0 12:10 12:30
F G
-1 00
1 00
-1 00 1 00
-100
100
-100 100
plectin+/+ plectin-/-
*
*
*
0
10
20
30
40
50
1 2 3 4 5 6 7 8 9 10 11 12
Lenghtof Fragments [µm]
%
of
fra
gm
en
ts
plectin+/+
plectin-/-
0
0.2
0.4
0.6
0.8
1.0
†
P
ro
ce
ss
iv
e
In
de
x
plectin+/+ plectin-/-
0
0 2.
0 4.
0 6.
0 8.
1.0
1 2.
0 50 100 150 200 250
Total Distance [ m]m
P
ro
ce
si
ve
In
de
x
plectin+/+
plectin-/-
Figure 32. Time-lapse observations of vimentin intermediates in a spreading (live) fibroblast cell transfected with
GFP-vimentin. A, Images of vimentin squiggle movement in wild-type, and of vimentin fragments in plectin knock-
out (-/-) cells. Arrowheads, starting positions; arrows, actual positions. B, Process of fragmentation visualized in a
plectin knockout cell. Formed fragments are indicated with arrows. Bar = 10 µm. C, Statistical evaluation of squig-
gle and fragment sizes in wild-type versus plectin-deficient cells. D and E, Diagrams representing directionality of
processive migration of squiggles and fragments in wild-type (+/+) and plectin-deficient (-/-) cells. Five migration
tracks of squiggles/fragments are shown in each case. Asterisks correspond to squiggle/fragment tracked in A. F,
Statistical evaluation of processive indexes. G, Scatter diagram showing processive indexes as a function of total
distances. Data shown represent mean values (± SEM) of five independent experiments (13 trajectories were meas-
ured). †, P < 0.001.
spreading cells. Granules and squiggles observed in lamellipodial regions of live cells (Fig.
32A, upper row) were indistinguishable regarding shape and dimensions from those
visualized in fixed (untransfected) spreading cells using immunofluorescence microscopy.
Granules and squiggles containing GFP-tagged vimentin were motile, showing movement
preferentially towards peripheral regions of the cells (Fig. 32A, +/+). Squiggle movement
was linear and continuous as is evident from the positions of the arrow in Fig. 32A, +/+,
which marks the actual positions of a squiggle relative to that of its starting position
(arrowhead).
When similar experiments were carried out with plectin-deficient fibroblasts, GFP–
tagged vimentin was found incorporated mostly into filamentous networks and what
appeared to be fragmented filaments, but granules and squiggles typical for wild-type cells
were not visualized (Fig. 32A, -/-). The discontinuous filamentous structures observed in
plectin-/- cells in general were significantly longer than typical squiggles and they were
lacking any directional movement; instead they were bending rather stochastically, remaining
at one and the same place (Fig. 32A, -/-). In fact, fragment formation from preexisting
vimentin networks, could occasionally be observed, as shown for two examples in Fig. 32B,
where fragmentations were captured at two different time points of one movie series. Similar
fragments were observed in fixed, untransfected spreading cells (Fig. 30A, k).
To quantitatively analyze differences between squiggles typical for wild-type cells
and filament fragments observed in plectin-/- cells, I performed statistical analyses of the
size and directionality of the movement of both structures (Fig. 32C-G). The average size of
vimentin fragments in knockout cells was 6-8 µm, while that of squiggles ~2 µm (Fig. 32C).
Quantization of the directionality of processive squiggle movement along five migration
tracks revealed relatively straight migration paths in wild-type cells (Fig. 32D; migration
path marked by asterisk represents squiggle shown in Fig. 32A, +/+). In contrast, a similar
analysis of representative fragments in plectin-/- fibroblasts revealed that they traveled along
chaotic and nonlinear paths (Fig. 32E; non-migrating fragments shown in Fig. 32A, -/-, are
indicated by asterisks). Calculating the processive index (PI) of movement, where PI is
defined as the linear distance between the start and end points divided by the total distance
traversed by the fragment, squiggles of plectin+/+ fibroblasts had an average PI of 0.77,
approaching the ideal PI of 1.0 for linear migration, while fragments in plectin-/- fibroblasts
reached an average PI of 0.088 (Fig. 32F and G).
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In all, these time lapse experiments not only confirmed that IF squiggle formation in
fibroblasts was plectin-dependent, but more importantly, they also suggested that plectin
was important for the directional transport of squiggles towards the cell periphery, as short
filaments, generated by the partial fragmentation of the IF network in plectin-/- cells, were
found to lack such oriented movement.
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9. DISCUSSION
Plectin is a cytoskeletal protein that forms dumbbell-shaped homodimers comprising a
central parallel α-helical coiled coil rod domain flanked by two globular domains. Its
molecular backbone seems ideally suited to mediate the protein’s interactions with an array
of other cytoskeletal elements. Plectin self-associates, interacts with actin and IF cytoskeleton
networks, and binds to the hemidesmosomal transmembrane protein integrin β4 as well as
other junctional proteins (reviewed in Rezniczek et al., 2004). Consisting of six structural
repeats and harboring binding sites for different IF proteins and proteins involved in
signaling, plectin’s C-terminal domain is of strategic functional importance. Plectin is also
a target of Cdk1 kinase and during mitosis it becomes phosphorylated at a unique site
(threonine 4542) in plectin’s C-terminal repeat 6 domain (Malecz et al., 1996), not far from
the IF-binding site residing in the linker region between repeat domains 5 and 6.
In view of plectin’s enormous size (>500 kDa) and exposure to mechanical stress
forces, the question arises how the molecule maintains its structural integrity. Four highly
conserved residues of at least 13 cysteines in the C-terminal part of plectin are clustered in
its repeat 5 domain (Wiche et al., 1993; Liu et al., 1996; Elliott et al., 1997; Fuchs et al.,
1999). Forming intra- and inter-repeat disulfide bridges, these cysteines could serve a
functional purpose, providing structural rigidity to the protein. Furthermore, the formation
of reversible intracellular disulfide bridges could modulate the response to mechanical,
oxidative, or other types of stress. My studies provided evidence that at least one of the
cysteines was reactive as reflected by its ability to form disulfide bridges and to serve as a
target for nitrosylation.
Previous studies have demonstrated that vimentin networks are highly dynamic
structures whose assembly and disassembly is accomplished stepwise via several
intermediates (Prahlad et al., 1998). The intermediate forms as well as filamentous vimentin
are found in cells in a dynamic equilibrium characterized by the turnover of the subunits
within the polymer and the movement of the precursor intermediates. I found that plectin is
associated with vimentin from the early stages of assembly and is required for vimentin
motility as well as for the stepwise formation of stable filaments.
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9.1. Cysteines proximal to the IF-binding site of plectin
Structural implications of repeat 5 domain cysteines
The building block of plectin’s C-terminal domain is a repeat domain known as the plakin
or plectin repeat domain (Janda et al., 2001; Leung et al., 2002). Repeat domains consist of
a conserved core domain or module, separated from each other by linker sequences of
variable lengths. The three repeat domains in desmoplakin were proposed to have an
independent structure arranged into “beads-on-a-string” (Choi et al., 2002). In contrast, Janda
et al. (2001) proposed a model where the six repeat domains of plectin are packed against
each other, with repeats 1-5 arranged around the central repeat 6 domain, forming a compact
C-terminal globular domain. Cysteine disulfide bridges could contribute to stabilizing this
structure in addition to the reciprocal hydrogen bond interactions mediated by hydrophobic
residues (Janda et al., 2001). The conception of compact plectin repeat packing is supported
by electron microscopy, visualizing the C-terminal domain as a globule of 9 nm diameter
(Foisner and Wiche, 1987). Homology modelling of each of the six plectin repeats based on
the known structure of the corresponding desmoplakin repets (50-73% sequence identity)
yielded a cylinder-like configuration with an average size of 45x25 Å. Therefore,
accommodation of six repeats within a 9 nm globule would indeed require tight packing of
the repeats rather than a loose beads-on-a-string arrangement.
Cross-linking experiments revealed that two of the four cysteines in the repeat 5
domain, Cys1 and Cys4, could form intramolecular disulfide bridges, and that the oxidized
form of repeat 5 domain migrated faster in SDS-PAGE than the reduced form, suggesting
conformational changes of the repeat 5 domain upon oxidation. As the modelling of the
repeat 5 domain revealed Cys1 to be partially buried in the core of the protein, the presence
of the linker in the cross-linked repeat 5 domain species probably caused a change in its
local conformation, exposing the vicinity of Cys1 on the surface and promoting the formation
of a disulfide bridge.
Repeat 4 has a single cysteine in a position equivalent to Cys2 of the repeat 5
domain; this cysteine can form disulfide bridges with cysteines of the repeat 5 domain
linking these repeats together. It can be assumed that corresponding cysteines in the other
repeats behave similarly. These findings support the model suggested by Janda et al. (2001).
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Functional implications of repeat 5 domain cysteines as a target for nitrosylation
Plectin-binding to IFs is essential not only for the mechanical stabilization of the
cytoskeleton due to plectin’s role as a cytolinker, where it interlinks different cytoskeletal
proteins and anchors them to the plasma membrane, but also for the proper IF cyto-
architecture with important consequences for signaling cascades controlling basic cellular
functions (Osmanagic-Myers and Wiche, 2004; Gregor et al., 2006; Osmanagic-Myers et
al., 2006).
Data obtained in my thesis showed that the reduced form of plectin’s repeat 5 domain
binds more efficiently to vimentin than its oxidized form. The dissociation constant of the
R5 Cys-free mutant (0.96x10-7 M) was 2x and 3x lower than that of the reduced and oxidized
forms of the repeat 5 domain, respectively. The substitution of a cysteine with a serine being
limited to the exchange of an –SH group with an –OH group is a quite conservative
mutation, which is not expected to cause a conformational change by itself. This could be
the case, however, if the substitution disrupts the formation of one or more disulfide bridges.
Because I have shown that Cys1 and Cys4 easily form a disulfide bridge that could alter
the conformational parameters of the repeat, the finding that the cysteine-free mutant and the
reduced form of repeat 5 domain bind better to vimentin could be interpreted as a signal
that, when the repeat 5 domain is in a reduced, i.e. more open conformation, the vimentin-
binding site might be more exposed, facilitating its interaction. Not only cysteines inside
the repeat 5 domain could influence plectin-vimentin affinity, but also neighboring repeats
4 and 6 and/or their cysteines, as well as the tail region. While the presence of repeat 4 and
6 domains led to an increased affinity comparable to the reduced form of the repeat 5 domain
alone, the presence of the tail region had a negative effect on the binding of plectin R5-6tail
to vimentin. These findings suggest that cysteines affect the conformation of repeat domains,
which in turn modulates the binding to vimentin.
In contrast to its reduced form, the oxidized form of the repeat 5 domain appears to
adopt a conformation where the vimentin-binding site is inaccessible. A plectin molecule
unable to bind to vimentin could severely affect cellular functions known to be IF-dependent,
including structural reinforcement of the cytoplasm and control of signaling cascades, similar
to the plectin-null situation (Osmanagic-Myers and Wiche, 2004; Gregor et al., 2006;
Osmanagic-Myers et al., 2006). In the cellular context, reversible in vivo modifications of
Cys4 by local redox changes could lead to either cysteine oxidation through reactive oxygen
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species (ROS), or to S-nitrosylation through reactive NO. In addition, ROS could convert NO
into higher oxides of nitrogen and radicals, such as peroxinitrite, which efficiently oxidizes
thiol groups (Lane et al., 2001).
This study showed that Cys4 in repeat 5 domain is highly reactive and that plectin
is a target for nitrosylation in vitro and in vivo. S-nitrosylation of cysteines leading to
nitrosothiols is a biochemical posttranslational modification of proteins that allows cells to
respond to environmental changes in specific subcellular compartments, and can modulate
protein activity in a fashion analogous to phosphorylation (Lane et al., 2001). Despite the
existence of cysteine residues in virtually all proteins, proteomic analysis of S-nitrosylated
proteins in extracts from brain (Jaffrey et al., 2001), mesangial cells (Kuncewicz et al., 2003),
and intact endothelial cells (Martinez-Ruiz and Lamas, 2004) revealed that S-nitrosylation
is restricted to a small number of proteins. Furthermore, S-nitrosylation is not a function of
total cysteine content, since generally, only one single cysteine thiol in the protein is
modified. The specificity is determined by structural motifs around the cysteine and the
intracellular proximity to a NO generator, such as the enzyme nitric oxide synthase (NOS),
which produces NO through the conversion of L-arginine into L-citrulline. Both requirements
seem to be fulfilled by Cys4 in plectin’s repeat 5 domain. The residues upstream (QE) and
downstream (E) of Cys4 perfectly match the consensus motif for S-nitrosylation.
The results obtained in studies on endothelial cells suggested that plectin may play
an important role in the distribution of eNOS, one of three isoenzymes of NOS differentially
expressed in different cell types. In wild-type cells I found activated eNOS to be distributed
over the whole cytoplasm, and this distribution stayed unchanged upon treatment of cells
with eNOS activator. In contrast, in plectin-deficient cells eNOS was localized mainly at
the plasma membrane, representing its inactive form. These findings were in accordance
with NO production measurements, which revealed decreased NO production in plectin-
deficient cells. Thus, plectin could be responsible for the observed alterations in eNOS
activity due to the altered distribution of eNOS over the cytoplasm.
Although the association of endogenous NOSs with plectin and their colocalization
in different cell types and tissues has not yet been studied comprehensively, there is solid
evidence for the intracellular proximity of nNOS and plectin in skeletal muscle. nNOS was
found to be targeted to the dystrophin-associated protein α1-syntrophin at specialized
structures on the surface membrane of muscle fibers, such as neuromuscular junctions
93
(NMJs), myotendinous junctions (MTJs), and costamers (Stamler and Meissner, 2001).
Plectin, as a prominent component of NMJs, MTJs, and costamers, is also associated with
the sarcolemma and has been found to colocalize with dystrophin (Schröder et al., 2002;
Hijikata et al., 2003; Konieczny et al., 2008).
Role of plectin in NO-induced IF collapse
Assessing whether S-nitrosylation of plectin effected by exposing endothelial cells to NO
donors had any effects on cellular cytoarchitecture, I found an interesting link between
plectin deficiency and the dynamics of IF network formation. While in wild-type cells, well
spread cellular vimentin networks largely persisted (for up to 6 h) after treating cells with
the NO donor SNAP, in plectin-deficient cells, I observed a progressive collapse of vimentin
filament networks into perinuclear bundles. One explanation for this phenomenon could be,
that plectin protects vimentin against oxidation. Vimentin, like all other members of type
III IFs, contains a single cysteine residue at a highly conserved position (328 in the human
protein). The corresponding residue in desmin has been shown to form disulfide bridges
leading to crosslinked dimers within filaments (Quinlan and Franke, 1982), and in
cytoskeletal preparations from baby hamster kidney and human glioma (astrocytoma) cells
a certain proportion of disulfide-crosslinked heterodimers, consisting of vimentin and
desmin, or GFAP, respectively, has been reported (Quinlan and Franke, 1982, 1983). In fact,
vimentin’s thiol is oxidized in preference to other cytoskeleton proteins in fibroblast-like
synoviocytes upon exposure to H2O2 (Rogers et al., 1991). Furthermore, these cells showed
increased susceptibility to vimentin collapse around the nucleus on exposure to oxidative
stress, and vimentin IFs in rheumatoid synoviocytes are more susceptible than in normal
synoviocytes, bearing a possible pathological significance (Rogers et al., 1989). The proposal
that synoviocyte vimentin becomes glutathionylated (Rogers et al., 1991) has recently been
confirmed by proteomic approaches showing that vimentin is glutathionylated in human T
lymphocytes and rat aortic smooth muscle cells (Fratelli et al., 2002; West et al., 2006).
Finally, prostanylation of the vimentin thiol has been found in mesangial cells (Stamatakis
et al., 2006) and its nitrosylation in endothelial cells (Yang and Loscalzo, 2005).
By binding to vimentin, plectin may either sterically hinder the access of oxidants and
thus prevent or impede IF collapse or prevent vimentin molecules from assuming a
confirmation enabling vimentin-vimentin disulfide bridge formation. There is evidence, at
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least from in vitro experiments, that disulfide crosslinked vimentin homodimers or desmin-
vimentin heterodimers were filament assembly-incompetent under nonreducing conditions
(Fraser and MacRae, 1985; Traub et al., 1993). The proposed shielding effect of plectin on
vimentin’s thiol group may be further enhanced by the multitude of proteins bound to its
surface as a consequence of its scaffolding function (Osmanagic-Myers and Wiche, 2004).
Alternatively, transient nitrosylation of Cys4 in plectin’s repeat 5 domain may promote its
subsequent disulfide bond formation with the unique cysteine of vimentin, thereby preventing
its bond formation with another vimentin molecule, eventually leading to filament collapse.
In fact, the results of my studies indicate that repeat 5 domain Cys4 of plectin can form
disulfide bridges with the unique cysteine of vimentin in vitro.
Another conceivable way how plectin might affect NO-induced IF network collapse
involves protein phosphorylation. The reversible process of phosphorylation/dephospho-
rylation of IF subunit proteins has been well established as a cellular mechanism leading to
the disassembly of IFs. Recently, it has been found that the collapse of keratin networks,
induced by the protein phosphatase (PPase) inhibitor ocadaic acid (OA), in keratinocytes
proceeds considerably faster in plectin-deficient compared to wild-type cells (Osmanagic-
Myers et al., 2006). This finding also applies to the vimentin network of fibroblasts
(unpublished data, M. Gregor). Several groups have reported an inhibition of PPases by
endogenously produced ROS, and it has been shown that the exposure of purified PPases to
NO donors leads to reversible enzyme inhibition (Caselli et al., 1995; Callsen et al., 1999;
Xian et al., 2000). Furthermore, NO activates serine/threonine kinases, including cGMP-
activated protein kinase (PKG), as well as various tyrosine kinases (Denninger and Marletta,
1999; Lincoln et al., 2001). Thus, the NO-triggered accelerated collapse of the vimentin
network in plectin-deficient endothelial cells, similar to OA-treated cells, could be caused by
protein hyperphosphorylation, affected by NO-activated phosphorylation. The mechanism
how plectin counteracts/antagonizes hyperphosphorylation of vimentin networks in wild-
type endothelial cells remains to be revealed. One can expect, however, that similar to other
cell types, plectin influences the cytoarchitecture of the IF network and thereby regulates
certain signaling cascades (Osmanagic-Myers and Wiche, 2004; Osmanagic-Myers et al.,
2006).
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Plectin deficiency affects NO production by eNOS
Assessing whether S-nitrosylation-induced IF collapse in the absence of plectin has any
consequences on the correct function of eNOS, my studies revealed that NO production by
eNOS was strongly affected in plectin-deficient cells. In contrast to wild-type endothelial
cells, in the absence of plectin, NO production was dramatically decreased to hardly
detectable values. These observations were confirmed by the analysis of protein levels of
eNOS in plectin+/+ and plectin-/- cells. Neither activated eNOS (specifically phosphorylated
on threonine 495 or serine 1177) nor total eNOS expression were hardly detectable in
plectin-deficient cells. The protein level and activation status of the upstream eNOS activator
Akt kinase stayed unchanged, suggesting that eNOS activity affected by plectin deficiency
was not an indirect effect on activators/inhibitors, but that plectin can directly regulate eNOS
protein expression. To explain and mechanistically link NO donor-induced IF collapse,
decreased NO production, and decreased eNOS protein levels, two possibilities should
considered. One is, that in the absence of plectin NO production and/or eNOS activity is
abolished as a protection of cell against nitrosylation-induced IF collapse. Another
conceivable explanation might be, that nitrosylation-induced vimentin network collapse alters
the normal function of eNOS, i.e. NO production.
Collapse of the vimentin filament network and/or decreased NO production probably
compromises the normal ability of endothelial cells to respond to an appropriate stimulus
causing vasodilatation in smooth muscle. As such a dysfunction is thought to be a key event
in the development of atherosclerosis and has also been shown to be of prognostic
significance in predicting vascular pathological events, including stroke and heart attacks
(Kojda and Harrison, 1999), it will be of interest to investigate whether plectin integrity
plays a role in these diseases.
In conclusion, my studies have shown that cysteines residing proximal to the IF-
binding site of plectin’s repeat 5 domain have the ability to form disulfide bridges with
consequences for conformational and biochemical properties of the repeat domain. The redox
state of these cysteines was found to have an influence on vimentin-binding affinity, and
one of the cysteines was identified as a specific target for nitrosylation. The observation that
plectin-deficient endothelial cells were more sensitive towards NO donor-induced IF network
collapse than wild-type cells, suggests an antagonistic role of plectin in oxidative stress-
mediated alterations of the cytoskeleton and a possible role of a plectin-based cysteine as a
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regulatory switch. Furthermore, my studies revealed that NO production, as well as
expression levels of eNOS are plectin-dependent.
9.2. The role of plectin in the formation of vimentin filament intermediates
Vimentin network formation
Recent studies have revealed IFs as highly dynamic polymers, with three types of structures
(granules, squiggles, and filaments) coexisting in the cell. Particularly IF intermediates in the
form of granules and squiggles have an important role in the assembly of IF networks
(Prahlad et al., 1998). The smaller subunits were found to be motile, assembling into
polymerized IFs following a stepwise process (Prahlad et al., 1998; Chou and Goldman,
2000; Chou et al., 2007). Although the binding of plectin to IFs, in particular to vimentin,
has long been established using different methodologies (for review see Rezniczek et al.,
2004), it was only recently shown, that plectin affects the cytoarchitecture of IFs with
important consequences for cellular signaling and response to different types of stress
(Osmanagic-Myers et al., 2006). As the issue of whether plectin-binding affects dynamic
properties of IFs has not been addressed before, in this study I set out to investigate the
interaction of plectin with vimentin filament intermediates in situations where these
intermediates have been best defined, namely during cell-spreading and mitotic cell division.
Using immortalized and primary fibroblasts derived from wild-type and plectin-null
mice I found that plectin is already associated with small and medium-sized vimentin
filament intermediates (granules and squiggles, respectively), that are characteristics of the
cell spreading process. By contrast, these intermediates could not be detected in the absence
of plectin, and long, scarcely networked filaments were observed instead. These filaments
clearly assembled considerably faster than the more complex vimentin networks formed in
the presence of plectin. This could be explained by assuming that in the absence of plectin,
vimentin assembly proceeds without crossbridge stabilization, similar to the self-assembly
of IFs in vitro. In fact, there is evidence that plectin-/- fibroblasts contain higher levels of
soluble vimentin than wild-type cells suggesting that filaments are less stable (unpublished
data, M. Gregor). Furthermore, since the directional (anterograde) movement typical of
vimentin intermediates (Prahlad et al., 1998) took place only in the presence of plectin, my
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work suggests that plectin is required for both, the stepwise formation of a robust vimentin
network from granules and squiggles and the transport of these intermediate structures to the
cell periphery and other areas where they are required. Vimentin network fragmentation
observed in plectin-null cells apparently was a result of network instability due to the
absence of plectin. The collapse of keratin networks induced in keratinocytes by the protein
phosphatase inhibitor okadaic acid proceeds considerably faster in the absence of the plectin
(Osmanagic-Myers et al., 2006). Furthermore as revealed in this study, NO-donor induced
IF collapse in endothelial cell proceeds dramatically faster in plectin-deficient cells compared
to wild-type cells.
In general, the most widely proposed function of IFs would be to serve as mechanical
integrators of the cytoplasm. The formation of IF intermediates and their transport could
provide cells with an efficient mechanism for delivering IF building material to cytoplasmic
regions where mechanical stability is required. A possible mechanism how plectin is involved
in the formation and transport of intermediates could be, that plectin does so by crosslinking
vimentin filaments among themselves and probably to other structures, such as microtubules,
and by concomitantly scaffolding the additional proteins needed for the movement of
vimentin granules and squiggles. While microtubules are known to be associated with plectin
(Koszka et al., 1985; Svitkina et al., 1996), an association of plectin with kinesin has not yet
been reported, although kinesin could be recruited to the plectin scaffold via vimentin
(Helfand et al., 2002). Plectin could serve as a filament nucleation center by acting as a
platform for all other molecules required for the formation of granules. In the absence of
plectin, when these nucleation centers are not present, granules cannot be formed and the cell
is presumably using an alternative method for IF network formation. Hypothetically, in this
case the network is formed by simple self-assembly of IFs from the basic building
components – vimentin tetramers – and this formation is not under precise control like in the
presence of plectin.
Vimentin dynamics during mitosis and cytokinesis
Cytoplasmic IF proteins in interphase cells typically form a network that extends from the
nuclear surface towards the cell periphery, but as cells enter into mitosis IFs undergo a
intensive reorganization upon phosphorylation by Cdk1 (Franke et al., 1982; Chou et al.,
1991). The fate of vimentin as it passes through the cell cycle seems to be dependent on the
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cell type. In mitotic BHK-21 cells, the interphase IF network, composed of vimentin and
desmin, is completely disassembled into non-filamentous granules (Rosevear et al., 1990).
In PtK2 epithelial cells both vimentin and keratin IF networks remain intact during the
mitotic process (Aubin et al., 1980). In HeLa cells, which also possess keratin and vimentin
networks, the keratin IF network is disassembled into spheroid bodies, whereas vimentin
remains filamentous (Franke et al., 1982; Jones et al., 1985).
Plectin is also phosphorylated by Cdk1, experiencing structural changes and
dissociating from vimentin filaments. Foisner et al. (1996) documented that plectin changes
from a mostly IF-associated form during interphase to a more soluble, IF-independent, and
diffusely distributed form in mitosis. By reexamining this issue using new strategies and
focusing on plectin’s interaction with dynamic forms of vimentin, my present study revealed
that a fraction of plectin remains associated with vimentin throughout mitosis. Furthermore,
phosphorylation of vimentin by Cdk1 in vitro was found not to decrease plectin-vimentin
binding affinity, indicating that plectin can interact with vimentin under conditions where
vimentin filaments are disassembled. The residual plectin-associated vimentin filaments
found in wild-type cells appeared dispersed over the whole cytoplasm, and the daughter cells
rebuilt their vimentin networks via intermediate forms (granules and squiggles) in a similar
fashion as during spreading after trypsinization and replating. In contrast, in cells lacking
plectin, discontinuous forms of filamentous vimentin prevailed. No intermediate forms were
observed in these cells as they rebuilt the vimentin network upon cytokinesis.
In many cell types filamentous vimentin forms cage-like structures surrounding the
mitotic apparatus during all stages of mitosis (Aubin et al., 1980; Zieve et al., 1980). Plectin,
serving as a structural cross-linker, regulates cell cytoarchitecture, connects microtubules to
other filaments systems and recruits signaling molecules to its surface. In fact, plectin has
been shown to be associated with microtubules assembled in a mammalian mitotic extract
together with 15 other proteins with known functional roles in spindle assembly (Mack and
Compton, 2001). It is thus conceivable that plectin promotes crosstalk between IFs and
mitotic spindle components. Loss of such cross-linkages and/or altered vimentin network
cytoarchitecture in plectin-deficient cells could consequently lead to a delay in progression
through mitosis and completion of cytokinesis. Therefore, the observation that after
nocodazole release plectin-null cells passed through mitosis faster than wild-type cells could
be accounted for by the lack of supracytoplasmic organization brought about by plectin
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networking, leading to a fully disassembled state of vimentin filaments in the absence of
plectin. Furthermore, the unequal distribution of vimentin into daughter cells in wild-type as
opposed to the more even distribution in plectin-null cells, may reflect the still partially
assembled and squiggle-associated, versus the disassembled and more soluble states of
vimentin.
Oddly, there is not yet any report about unequal distribution of IFs during mitosis.
However, already in the early publication of Aubin et al. (1980) an obviously unequal
distribution of vimentin during telophase and cytokinesis in PtK2 cells is clearly visible. To
our knowledge, this very interesting phenomenon has not yet been noticed in other cell types.
However, an unequal distribution of several proteins has been described during asymmetric
cell division (Knoblich, 2001). My observations revealed, that unequal distribution of
vimentin occurred in fibroblasts, when two daughter cells with different sizes were formed.
So far, asymmetric cell division has been described only for the C. elegans zygote,
neuroblasts, the precursors of the central nervous system and several types of stem cells
(Knoblich, 2001; Wildner et al., 2006; Gonzalez, 2007). Asymmetric cell divisions provide
a mechanism for placing specific cell types into defined positions in the developing organism
(Horvitz and Herskowitz, 1992). Plectin could be partially responsible for this phenomenon,
as the completely disassembled vimentin in plectin-null cells was found distributed equally
to the newly formed daughter cells. In general, very little is known about how the
distribution of the cytoskeleton is regulated during cell division. Cdk1-induced vimentin-
Ser82 phosphorylation plays an important role in vimentin filament segregation, together
with Rho-kinase and Aurora-B kinase (Yamaguchi et al., 2005).
Phosphorylation and formation of vimentin filament intermediates
IF granules, as transporting reservoirs, were described as possible basic building blocks for
filamentous IF network assembly (Aubin et al., 1980; Franke et al., 1982; Rosevear et al.,
1990; Prahlad et al., 1998; Chou and Goldman, 2000; Helfand et al., 2003). I show evidence
that plectin plays an essential role in the formation of vimentin granules, which are formed
upon phosphorylation and have plectin associated with them.
The first question arising is why such globular structures are formed and what
advantage they pose for the cell. As described above, these structures were observed during
early stages of cell spreading when IF formation started. The cell needs some mechanism
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how to transport IF material effectively under appropriate control to the regions where it is
needed. Formation of reservoir granules seems to be an ideal form how to effectively pack
the IF material and quickly transport it to the required regions. To transport single molecules
as well as some longer filamentous structures seem to be energetically ineffective. This is
in accordance with the findings, that as granules get prolonged into longer filaments their
speed is decreased with increasing length (Chou and Goldman, 2000; Helfand et al., 2002).
On the other hand, local assembly of IFs from IF intermediates suggests that cells need to
regulate the local amounts of vimentin in a precise manner, particularly in rapidly spreading
regions. The functional significance of such an assembly mechanism may be related to the
role of IFs as mechanical cell shape stabilizer and mediators of cytoskeletal interactions
(Goldman et al., 1996; Fuchs and Cleveland, 1998).
Another question which arises is what molecular structure and composition these
granules have. The factors that maintain vimentin in its non-filamentous intermediate state,
or promote its polymerization into IF are unknown. Previous studies have shown that the
formation of protofilamentous vimentin globules is correlated with the phosphorylation of
vimentin by Cdk1 (Chou et al., 1990; Chou et al., 1996). Therefore, the state of phospho-
rylation may also regulate the conversion of non-filamentous vimentin granules to
filamentous 10 nm filaments. The local control of phosphorylation may also disassemble
selectively some of the filaments into smaller structures, such as granules, in one region of
the cytoplasm for rapid transport to other regions. This regional control of IF phosphorylation
could provide a mechanism for enhancing the dynamics of IF networks in regions where
the cytoskeleton is to be rapidly reorganized.
As discussed above, plectin may serve as a nucleation center for the formation of
granules, the basic building blocks of IFs, and phosphorylation keeps vimentin in non-
filamentous form. Meeting these two criteria seems sufficient for the formation of IF
granules, as confirmed by my in vitro data, showing that Cdk1-phosphorylates vimentin in
the presence of similarly phosphorylated plectin was able to form globular structures
resembling vimentin granules observed during spreading. IF granules have been reported in
many cell types, like in fibroblats (Prahlad et al., 1998) nerve cells (Yabe et al., 1999a),
epithelial cells (Windoffer and Leube, 1999b), or in several types of mitotic cells (Rosevear
et al., 1990). IF granules in spreading cells examined by electron microscopy appear to
consist of nonmembrane-bound globular vimentin aggregates (Prahlad et al., 1998), or
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aggregates of densely packed cytokeratin granular particles with a diameter of 0.2-1.5 µm
(Franke et al., 1982). Until now little is known about the composition of these structures, but
I can hypothesize that these granules are at least composed of disassembled vimentin and
plectin (as nucleation factor) and probably kinesin or/and dynein (as molecular motors for
their transport).
It has previously been reported, that phosphorylation of plectin by serine/threonine
kinases, including mitotic Cdk1, decreases its binding affinity to vimentin (Foisner et al.,
1996). In this study, using a recombinant version of plectin containing its major IF-binding
domain, I confirmed these results by showing that the affinity of Cdk1-phosphorylated
plectin for unphosphorylated vimentin is lower, than when both proteins are either
phosphoryated or non-phosphorylated. Furthermore, my data revealed that the binding
affinities of Cdk1-phosphorylated and of non-phosphorylated forms of both proteins are very
similar, indicating that plectin and vimentin can bind to each other regardless of their Cdk1
phosphorylation status. This establishes that a fraction of both proteins could also stay
associated throughout mitosis. Thus a partial association of plectin with vimentin throughout
mitosis is likely to facilitate the rapid rebuilding of the IF network after cytokinesis.
Previously, Skalli et al. (1992) reported that plectin and vimentin remain associated in BHK
cells during mitosis and suggested that the binding of plectin to vimentin is not significantly
altered when both proteins are phosphorylated by Cdk1. Finally, the observed high affinity
of unphosphorylated plectin to phosphorylated vimentin would be consistent with a model
where dephosphorylation of plectin after mitosis occurs prior to that of vimentin, promoting
reassociation of the entire vimentin pool with plectin.
Taken together my studies show that plectin prevents vimentin networks from
complete disassembly during mitosis, facilitating the rebuilding of the IF network in daughter
cells. In this scenario, plectin may serve as a nucleation center for the formation of vimentin
intermediates, enabling them to recruit molecular motors and anchoring proteins required
for their transport and targeting to specific intracellular destinations. Furthermore, a better
understanding of how the transport of IFs is regulated should shed new light on the
molecular basis of numerous human diseases, such as amyotrophic lateral sclerosis and
Parkinson’s disease (Toyoshima et al., 1989; Galloway et al., 1992; Xu et al., 1993), whose
pathological characteristics include abnormal aggregation of IFs in axons and skin fibroblasts
combined with giant axonal neuropathy (Pena, 1982; Bousquet et al., 1996).
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